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Perinatal mental health issues including depression, anxiety, posttraumatic stress 
disorder, mania, and psychosis occur frequently during pregnancy and after delivery; 
these issues have potentially devastating impacts on mothers, infants, other family 
members, and communities.  Despite increasing awareness of perinatal mental health 
issues and formal recommendations to implement universal screening and ensure access 
to appropriate follow-up, there is wide variation in clinical practice across regions and 
providers.  Inconsistent screening, paired with limited local resources for follow up, 
might prevent women from receiving appropriate treatment.  The objective of this project 
was to develop a guide for clinician use to improve screening, referral, and follow up of 
perinatal mental health issues.  The guide identifies an appropriate screening instrument, 
screening intervals, methods, recording practices, and follow-up recommendations.  
Additionally, an integrated mental health model was proposed for ongoing treatment and 
coordination of care.  The project was developed using the Delphi method and ongoing 
engagement with seven local stakeholders to create a streamlined, consistent process that 
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Perinatal mood and anxiety disorders (PMADs) are one of the most common 
complications of pregnancy and childbirth.  It is estimated that across the population, up 
to one in seven women who are pregnant or give birth have experienced PMAD 
symptoms with even higher incidence in women with elevated risk factors (Earls, 2010; 
O’Hara & Wisner, 2014).  Perinatal mood and anxiety disorders can occur at any time 
during pregnancy or the postpartum period and include depression, anxiety, mania, and 
psychosis (Hanley, 2009).  These disorders may be debilitating for women and can 
interfere with infant attachment and bonding, possibly impacting families for generations.  
Perinatal mood and anxiety disorders also impact fathers, same-sex parents, grandparents, 
and siblings.  Anxiety and depression during pregnancy are independent risk factors for 
cesarean delivery, preterm birth, and low birth weight (Hanley & Oberlander, 2014).  
Babies born to women experiencing PMADs often require higher levels of care in early 
infancy and frequently have difficulty with sleep and temperament (Hoffman, Dunn, & 
Njoroge, 2017).  Severe maternal stress during the first trimester has been associated with 
increased risk of congenital malformations; prenatal stress at any point during pregnancy 
increases the risk of depression, anxiety, and behavioral issues in offspring (Glover, 
2014; Hoffman et al., 2017).   
  Despite increasing awareness of PMADs and their impact, as well as 
recommendations from professional organizations including the American College of 
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Obstetricians and Gynecologist (ACOG, 2016), the U.S. Preventive Services Task Force 
(USPSTF, 2018), and the American Academy of Pediatrics (AAP, Earls, 2010), many of 
the providers who care for pregnant/postpartum women and their babies do not routinely 
screen for these disorders, leaving many women without proper diagnosis and treatment 
(Cox, Sowa, Meltzer-Brody, & Gaynes, 2016).  Reasons often cited for not routinely 
screening for PMADs include lack of time, lack of institutional support, and unfamiliarity 
or discomfort with mental health issues.  Even if women are screened and identified as 
having or being at risk for developing PMADs, providers often lack access to appropriate 
resources to which the women could be referred.  Developing comprehensive practice 
guidelines for screening, assessment, referral, and treatment of PMADs might improve 
outcomes for women, their children, their families, and communities (Cox et al., 2016; 
Evans, Phillippi, & Gee, 2015).   
Significance of the Problem 
Kootenai County is located in the northern “panhandle” region of Idaho.  Home to 
some 150,000 people, an estimated 1,800 babies are born in the county annually.  
Approximately 53% of prenatal, obstetric, and postnatal care is rendered by providers at 
Kootenai Health (2018), a community-owned hospital.  Until recently, Kootenai Health 
had not had any formal guidelines or protocols to direct screening for perinatal mental 
health issues.  Within the past 24 months, the outpatient obstetrics-gynecology clinic has 
begun screening women at the first obstetric (OB) visit using the Patient Health 
Questionnaire-2 (PHQ; Kroenke, Spitzer, & Williams, 2003), and the PHQ-9 (Kroenke, 
Spitzer, & Williams, 2001) at the six-week postpartum visit.  Beyond this, there are no 
organizational guidelines for treatment or referral.  Currently, no universal screening 
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process is in place at the inpatient Family Birth Center (comprised of labor and delivery, 
post-partum, and a neonatal intensive care unit (NICU)).  Informal discussions with staff 
and leadership on the outpatient and inpatient sides of prenatal and obstetric care 
indicated a high level of interest in receiving education, support, and assistance in 
implementing routine screening, treatment, and referral.    
Several organizations in the community provide outpatient mental health services 
including psychotherapy, support groups, and medication management.  Several 
providers (including this writer) have interest and experience in treating PMADs but no 
formal system for referral exists between agencies nor is there any process for expediting 
treatment of women in urgent need of mental health assistance.   
Gap Analysis 
On national, state, and local levels, significant gaps exist between 
recommendations and actual clinical practice when it comes to screening, identification, 
and treatment of PMADs.  A meta-analysis by Yawn et al. (2012) found, “Despite nearly 
universal health care encounters at some time during [the perinatal period], only about 
50% of women with significant depressive symptoms are recognized” (p. 1).  Women 
with less pronounced symptoms are often less likely to be identified, especially when 
there is no formal, routine mechanism for assessment.   
In a 2015 review of literature, Evans, Phillippi et al. found that across obstetric, 
pediatric, and family practitioners, 3 in 10 rarely or never assessed for postpartum 
depression (PPD).  Slightly more than half of providers responded they “ever,” 
“sometimes,” “often,” or “always” assessed for PPD but, overall, only one in four 
routinely used a validated screening instrument.  The same authors found that while a 
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majority of providers in pediatrics, family practice, and obstetrics (OB) felt it was their 
responsibility to identify PPD, most of these providers reported feeling lack of 
confidence in their ability to do so.  Additional identified barriers to screening included 
time constraints, financial disincentives, concern over liability, inadequate availability of 
mental health services, and the perception that mothers did not want to disclose or discuss 
symptoms (Evans, Phillippi et al., 2015).   
 Even if screening is completed, multiple barriers can prevent women from 
receiving appropriate treatment including external barriers (lack of local resources, lack 
of insurance coverage) and internal barriers (avolition, shame, and stigma).  Cox et al. 
(2016) found only 15.8% of women identified as having PPD received treatment and only 
6.3% received “adequate” treatment.  Goodman (2009) found most women (92%) said 
they would engage in individual therapy to treat PPD if it was recommended and 
available.  Women indicated a preference to receive treatment in their OB providers’ 
office, either by the obstetric provider or by a mental health professional.  Even if women 
with or at high-risk for PMADs were identified and referred to a mental health 
professional for further assessment and treatment, follow-through was variable.  Puryear 
(2018) found in women identified as being high-risk for PMADs, the rate of completed 
follow-up for mental health evaluation was only 21.1% when the mental health 
provider’s office was in a separate location from the OB provider’s office but as high as 
81.1% when the mental health provider was embedded in the OB office.  
 Very little published information is available regarding incidence or treatment of 
PMADs in Idaho but abundant data indicate that mental health services in Idaho are 
generally inadequate and unable to match the needs of the population.  According to 
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Mental Health America (2018), a national non-profit mental health advocacy 
organization, Idaho ranked 42 out of 51 (U.S. states and the District of Columbia) in 
terms of access to mental health care.  In 2016, Idaho had the eighth highest suicide rate 
in the nation with 20.8 completed suicides per 100,000 residents.  This rate is 50% higher 
than the national average, and makes suicide the second-leading cause of death of 
Idahoans between ages 15-34 (Idaho Department of Health and Welfare; Suicide 
Prevention Program, n.d.). 
In Kootenai County (n.d.), the third most populous county in Idaho, mental health 
services are provided by a variety of agencies including the community-owned hospital, 
the State Department of Health and Welfare, for-profit clinics, independent practitioners, 
and a federally qualified health center.  The community’s largest outpatient mental health 
provider is the federally qualified health center (Heritage Health), which provides 
primary care, dental, and mental health services to several thousand clients annually.  The 
mental health department is comprised of Heritage Mental Health, which provides 
primarily psychotropic medication management, and Family Support Services, which 
provides psychotherapy, community-based rehabilitation services, assertive community 
treatment, and an intensive outpatient treatment program.  Together, the departments 
employ 27 clinicians (primarily master’s level professional therapists or clinical social 
workers), two full-time psychiatric physician assistants (PAs), and one full-time 
psychiatric nurse practitioner (NP, Kootenai County, n.d.).  According to personal 
communication with the directors of Heritage Mental Health and Family Support 
Services, the average wait times for new-patient appointments for medication 
management and psychotherapy are two to three months and six to eight weeks, 
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respectively.  Both agreed no formal systems were in place for expedited referral for 
patients needing urgent care (including those with PMADs), and that such a system 
would greatly benefit the community.   
A preliminary survey of OB providers at Kootenai Clinic indicated many were 
starting to screen patients for PMADs in the outpatient setting and were aware of the 
importance of doing so—yet barriers persisted.  First, most providers who responded to 
the survey reported that despite screening regularly and being “familiar with screening 
recommendations,” they were not familiar with the Edinburgh Postnatal Depression Scale 
(EPDS; Mcbride, Wiens, Mcdonald, Cox, & Chan, 2014)—one of the most highly-
validated and recommended tools for screening in the perinatal period.  Despite recently 
implementing some screening into prenatal and postpartum care, detection of PMADs 
was still very low.  The Kootenai Clinic’s obstetrics-gynecology practice informally 
estimated they encountered one case of PPD per month but based on delivery rates and 
national incidence of PMADs, the number of affected women was likely more than 10 
times higher (J. Stotz, personal communication, October 2018).  A subsequent review of 
depression screening in the OB clinic using the PHQ-9 (Kroenke et al., 2001), a validated 
instrument used widely in primary care, indicated nearly one in five women (18.5%) 
rated “moderate/severe” or “severe” depression symptoms.  
Responses indicated that while some OB providers felt comfortable discussing 
mental health issues with perinatal women, they did not feel familiar with local resources 
for follow-up treatment.  Most respondents (80%) indicated that having a standardized 
guideline to standardize screening, referral, and follow up across clinical settings would 
greatly improve access to care and outcomes in this vulnerable population.   
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Background and Significance of Perinatal Mood  
and Anxiety Disorders 
Suicide Statistics 
In the developed world, suicide is a leading cause of maternal death during 
pregnancy and the first 12 months postpartum.  In the United States, more maternal 
deaths are due to suicide than to either hemorrhage or hypertensive disorders (Palladino, 
Singh, Campbell, Flynn, & Gold, 2011).  A recent study in Ontario, Canada, revealed 1 in 
19 maternal deaths was attributable to suicide (Grigoriadis et al., 2017).  The authors also 
noted these numbers were likely underreported (death certificates did not always 
accurately reflect pregnancy or recent childbirth) and underestimated (many only 
considered the postpartum period to extend six weeks after delivery), making the actual 
estimated incidence of perinatal suicide strikingly high.  According to a study in the 
United Kingdom from 1997-1999, 10% of all postpartum deaths were the result of 
suicide (Oates, 2003).  Evidence suggested the methods by which pregnant and 
postpartum women committed suicide were more violent than non-perinatal suicides 
(more likely to hang selves or jump; Palladino et al., 2011). 
Impact of Perinatal Mood and  
Anxiety Disorders on Children 
 
The effects of PMADs are not limited to mothers; they extend throughout the 
family and impact babies, siblings, partners, and communities.  The health impacts on 
babies of women experiencing PMADs have been well documented.  Severe maternal 
stress during the first trimester is associated with increased risk of congenital 
malformations (Glover, 2014).  Anxiety and depression during pregnancy have been 
identified as independent risk factors for caesarean delivery, preterm birth, and low birth 
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weight (Hanley & Oberlander, 2014).  Poor growth and reduced rates of breastfeeding 
(especially in first time mothers) are also potential effects of PMADs (Toler, Stapleton, 
Kertsburg, Callahan, & Tolsma, 2018). 
Babies born to mothers struggling with PMADs often require higher levels of care 
in early infancy.  They frequently have difficulty with sleep and temperament and are at 
elevated risk of depression, anxiety, and behavioral issues (Glover, 2014).  These infants 
are at risk of developing impaired social interactions, developmental delays, and 
language acquisition (Earls, 2010; Hoffman et al., 2017).  Impaired attachment and 
bonding can impede brain development in a neglected infant to the point that magnetic 
resonance imaging scans reveal visible, negative changes to brain structure (Earls, 
2010).  They may develop insecure attachment, putting them at risk for behavior 
problems later in life (Hoffman et al., 2017). 
Seymour, Giallo, Cooklin, and Dunning (2014) noted women with postpartum 
anxiety may be “insensitive to infants’ cues,” (p. 315), which can interfere with their 
ability to bond appropriately with their children.  Adverse effects of impaired attachment 
become more entrenched and resistant to intervention over time, highlighting the need for 
early detection and intervention for depressed mothers (Hoffman et al., 2017; Seymour et 
al., 2014).   
Impact of Perinatal Mood and  
Anxiety Disorders on Family 
 
 Perinatal depression often has a ripple effect on the entire family system.  If a 
mother experiences postpartum depression, her partner is more likely to also experience 
depression (Earls, 2010).  A correlation (though not clear causation) exists among 
perinatal depression and marital problems, substance abuse, and child abuse/neglect 
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(Norhayati, Hazlina, Asrenee, & Emilin, 2015).  Parental depression could lead to poor 
implementation of recommended safety measures (i.e., using car seats properly or 
following safe-sleep guidelines) and excessive utilization of healthcare resources (Earls, 
2010).   
Financial Impacts of Perinatal Mood  
and Anxiety Disorders 
Limited data exist regarding specific financial impacts of PMADs but much 
research confirmed the significant financial burden of depression in the United States and 
around the world.  Greenberg, Fournier, Sisitsky, Pike, and Kessler (2015) estimated the 
economic burden of depression (major depressive disorder, bipolar depression, and 
dysthymia) in the United States in 2010 to be approximately $81.1 billion.  The financial 
impacts of mental illness are multifactorial and include lost wages, lower productivity 
(due to missing work and struggling with cognitive challenges even if present at work), 
and significant medical comorbidities associated with increased healthcare utilization and 
spending (Greenberg et al., 2015; Kessler, 2012).  In 2004, depression was the fourth 
leading cause of disability adjusted life-years (DALY), a measure of life lost to premature 
death and years lived with disability (Briley & Lepine, 2011).  The World Health 
Organization (WHO, cited in Briley & Lepine, 2011) estimated that by 2030, depression 
would become the leading cause of DALY.  
Diaz and Chase (2010) estimated the annual cost of untreated maternal depression 
is $22,647 per mother/infant dyad.  This included lost wages and lower productivity by 
the mother, increased healthcare costs associated with the infant born to a depressed 
mother (risk of low birth rate, pre-term delivery), and downstream financial impacts to 
the child due to those complications.  Cox et al. (2016) extrapolated that in 2008 this 
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could have accounted for almost $15 billion annually.  It should be noted these financial 
estimates focused entirely on the economic burden of depression.  The impacts of 
anxiety, posttraumatic stress disorder (PTSD), mania, and psychosis were not quantified 
in the literature and likely carried equally high economic impacts.   
Risk Factors for Perinatal Mood  
and Anxiety Disorders 
Multiple factors elevate a woman’s risk of developing PMADs including history 
of anxiety or depression, history of interpersonal violence, adverse life events, unplanned 
pregnancy, physical illness or pregnancy complications, multiple births, sleep 
disturbance, low social and/or partner support, high perceived stress, high perceived 
childcare need, and low self-esteem (Paschetta et al., 2014; Toler et al., 2018).  The 
strongest predictive risk factors for perinatal depression are history of depression 
(perinatal or non-perinatal episodes) along with psychosocial factors (O’Hara & Wisner, 
2014; Paschetta et al., 2014;). 
Personal or family history of psychotic disorders, previous episodes of postpartum 
psychosis, younger age, and sleep disturbance increase the risk of postpartum psychosis 
(Paschetta et al., 2014).  Pregnancy complications including severe preeclampsia, 
cesarean delivery, lower birth weight, NICU admission, and perinatal death increase the 
risk of PTSD (Paschetta et al., 2014).   
Definition of Terms 
Two main diagnostic classifications systems used in psychiatry in the United 
States are the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5, American Psychiatric Association, 2013) and the 10th edition of the 
International Classification of Diseases (ICD-10) published by the WHO (2018).  Each 
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system uses a different, but sometimes overlapping, taxonomy to describe PMADs.  The 
DSM criteria are used widely for diagnostic and treatment purposes, while ICD-10 
criteria are used primarily for coding and billing. 
Neither the DSM-5 (APA, 2013) nor the ICD-10 (WHO, 2018) recognize 
postpartum depression as a separate diagnostic category.  According to the DSM-5, if the 
patient meets diagnostic criteria for a major depressive episode (five out of nine 
neurovegetative symptoms present nearly every day within a two week period, symptoms 
not attributed to another condition, and symptoms caused significant distress or 
impairment), the specifier of “with peripartum-onset” is to be added if symptoms began 
during pregnancy or within four weeks of delivery (ICD-10 expanded the postpartum 
period to six weeks after delivery; WHO, 2018).  The peripartum-onset specifier may 
also be added to episodes of Bipolar I and Bipolar II Disorders (including episodes of 
mania, hypomania, and depression; APA, 2013).   
Organizations devoted to improving identification and treatment of PMADs, 
including Postpartum Support International (PSI; Segre & Davis, 2013) and the Marcé 
Society (Austin, 2014), have advocated for expansion of the “peripartum-onset” modifier 
to include onset within the first six months after delivery.  In studies of postpartum 
women, depressive symptoms peak at six weeks, two to three months, and six months 
after delivery, rendering the four-week onset requirement overly restrictive and 
exclusionary (Earls, 2010; Sharma & Mazmanian, 2014).  Additionally, these 
organizations support application of this modifier to episodes of brief psychotic disorder, 
mixed depression and anxiety disorder, and obsessive compulsive disorder (Segre & 
Davis, 2013).  Postpartum Support International’s rationale for this expansion included 
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acknowledgement that many women who suffer from PMADs present to their primary 
care and obstetric providers with mixed symptoms of anxiety and depression and these 
diagnoses more accurately reflect their clinical presentations.  Of high concern was the 
incidence of obsessive compulsive disorder (OCD), which is very common in the 
postpartum period.  Symptoms include intrusive and ego-dystonic thoughts of harming 
oneself or one’s infant.  If not properly assessed and diagnosed, these thoughts are often 
mistaken for psychosis and women might be wrongly accused of being potential threats 
to themselves or their children, which delays treatment and can—in worst case 
scenarios—result in inappropriate engagement of child protective services (Segre & 
Davis, 2013).  If clinicians are able to confidently rely on DSM criteria to assess patients 
and therefore direct treatment, outcomes will be improved.  
As DSM-5 (APA, 2013) and ICD-10 (WHO, 2018) taxonomy have limited use in 
clinical practice, many stakeholders—including mental health professionals and 
obstetric/gynecological providers—have developed pragmatic, clinically useful terms for 
describing mental health issues in the perinatal period (Milgrom & Gemmill, 2014).  
Mood, anxiety, and psychotic disorders exist on a spectrum ranging from mild depression 
and anxiety to severe, life-threatening depression and psychosis.  Definitions and 
parameters might vary across clinical settings or cultures but the general consensus is 
these disorders begin during pregnancy or within the first 12 months after delivery (Earls, 
2010; Norhayati et al., 2015; O’Hara & Wisner, 2014).  It should also be noted that 
preexisting mental health disorders may be exacerbated during this time period 
(Fairbrother, Young, Janssen, Antony, & Tucker, 2015; Norhayati et al., 2015). 
13 
 
Baby blues.  Mild or moderate symptoms that usually occur in the first few days or week 
after delivery.  It is estimated that between 50-80% of postpartum women 
experience these symptoms including sadness, mood swings, tearfulness, anxiety, 
and worry.  These symptoms might be distressing but do not interfere with 
functioning and usually resolve within one to two weeks with support and 
reassurance (Earls, 2010; O’Hara & Wisner, 2014).  
Bipolar disorder.  Characterized by fluctuation in mood or energy states that last days to 
weeks at a time.  While popular culture focuses on episodes of mania (increased 
energy states with typically with decreased need for sleep, euphoria, impulsivity, 
risk taking behavior, and grandiose thinking), people with bipolar disorder (BD) 
generally spend significantly more time in a depressed state, which is often 
misdiagnosed as “unipolar” depression.  Women with BD are at elevated risk for 
episodes during and after pregnancy with up to 50% of women with bipolar II 
disorder experiencing depression postpartum (Mandelli et al., 2016).  
Contributing factors include gonadal steroid withdrawal after delivery and sleep 
deprivation due to circadian rhythm shifts and care needs of the newborn (O’Hara 
& Wisner, 2014).  Munk-Olsen et al. (2009) found that in the first 30 days 
postpartum, women with BD had a relative risk of 23.3 of having a psychiatric 
admission (compared to women at any other period postpartum).  Pregnancy and 
birth could be triggers for de novo mania and hypomania in women without 
previous BD diagnoses and up to 20.4% of women experience symptoms of 
hypomania after childbirth (Sharma, Al-Farayedhi, Doobay, & Baczynski, 2018). 
Hypomanic, manic, and mixed episodes tend to occur immediately after childbirth 
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(Sharma & Xie, 2011).  The elevated mood of hypomania might be misinterpreted 
as a normal joy of being a new parent and the diminished need for sleep might be 
obscured by the typical sleep disruption in the postpartum period.  While manic 
and hypomanic episodes can occur later postpartum, depressive episodes are 
much more common, affecting up to 50-75% of women with BD (Mandelli et al., 
2016). 
Obsessive compulsive disorder.  Mother has recurrent, intrusive, unwanted, and 
uncomfortable (ego-dystonic) thoughts—often of harming self or baby.  Baby is 
at low risk; the mother takes steps to protect baby (possibly overprotect) and does 
not want to harm it (Paschetta et al., 2014).  Occurs in up to 4% of women.  
Postpartum OCD is often misinterpreted as psychosis (O’Hara & Wisner, 2014). 
Perinatal anxiety.  Large umbrella term that includes generalized anxiety, panic, social 
anxiety, and obsessive compulsive disorders.  Reported rates vary with prevalence 
rates from 4.5% to 15% (Paschetta et al., 2014).  Prenatal anxiety is associated 
with adverse outcomes including miscarriage, low birth weight, preeclampsia, and 
premature birth.  Prenatal anxiety is a strong predictor of postpartum depression; a 
large-scale study found 66% of women meeting diagnostic criteria for a major 
depressive episode in the postpartum period also had comorbid anxiety disorders 
(Fairbrother et al., 2015). 
Perinatal depression (often called postpartum depression).  Includes profound 
symptoms including dysphoria, hopelessness, helplessness, anhedonia, avolition, 
crying spells, and possibly suicidal ideation.  Symptoms usually begin at least 
several weeks after delivery (but might be preceded by baby blues) and last at 
15 
 
least two weeks.  Untreated depression might persist for months or even years.  
Prevalence depends on definitions; if using strict DSM 5 (APA, 2013) criteria for 
major depressive disorder, Gavin et al. (2005) estimated prevalence of 7.2% 
within the first three months postpartum, whereas the incidence of more broadly 
defined depression was estimated at 19.2%.  A study of prevalence of depression 
during pregnancy estimated 18.4% with 12.7% meeting criteria for a major 
depressive episode (O’Hara & Wisner, 2014), indicating prenatal depression was 
just as prevalent as postnatal depression. 
Postpartum psychosis.  A break from reality that constitutes a medical emergency.  The 
mother might be confused or disoriented; she might experience hallucinations or 
delusions, for example, believing her baby is possessed by a demon or that she 
needs to kill the infant to “save” it.  These thoughts are ego-syntonic.  Symptoms 
can wax and wane with periods between episodes when the mother feels and 
appears normal.  Preexisting BD is a risk factor for developing postpartum 
psychosis; women who present with postpartum psychosis frequently meet 
diagnostic criteria for bipolar depression, manic, or a mixed-state, with psychotic 
features (O’Hara & Wisner, 2014).  Onset is generally within the first one to two 
weeks after birth and incidence is one to three per 1,000 births (Earls, 2010; 
Paschetta et al., 2014).  The risk of recurrence with subsequent pregnancies is 
between 30% and 50% (APA, 2013). 
Posttraumatic stress disorder.  Develops after exposure to a traumatic event associated 
with serious risk of death, injury, or threat to physical integrity.  Symptom-
clusters include re-experiencing the event (flashbacks, intrusive memories, or 
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nightmares), avoidance of reminders of trauma, negative thoughts or feelings 
about the trauma, and nervous system arousal related to the trauma (APA, 2013).  
Childbirth itself is frequently a risk factor for development of PTSD.  Women 
who experience traumatic births (requiring urgent or emergent medical 
intervention) or experience medical complications during pregnancy (including 
hyperemesis, preeclampsia, eclampsia, and preterm labor—especially if these 
require hospitalization—are at elevated risk of PTSD in the perinatal period 
(Grekin & O’Hara, 2014).  Other risk factors include history of non-birth related 
trauma, perceived low social support, and postpartum depressive symptoms 
(Grekin & O'Hara, 2014; Khoramroudi, 2018).  Postpartum PTSD prevalence 
ranges from 1% to 21% in community samples and up to 43% in high-risk 
samples (Khoramroudi, 2018). 
Doctor of Nursing Practice Project Purpose and 
Statement of Objectives 
The purpose of this Doctor of Nursing Practice (DNP) scholarly project was to 
develop a comprehensive guide to improve the mental health care provided to women in 
Kootenai County during the perinatal period.  Developing this guide required the 
engagement of multiple stakeholders including OB and mental health providers, nursing 
and social services staff, and administrative staff.  The guide recommended the following 
based on stakeholder consensus: 
1. An appropriate screening instrument 
2. Appropriate screening intervals 
3. Screening method and process for recording results in the medical record 
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4. Specific actions the clinician should take based on pre-established cutoff 
scores 
5. A method for transferring care and assessing follow up once risk or 
symptoms have been identified. 
The final objective necessitated proposal of an integrated mental health model.  
Implementation of the proposed guide and model will occur outside the scope of this 
scholarly project given the significant institutional and financial investment required.  
Developing the scholarly project built a foundation and framework for such a program, 
served to mobilize stakeholders, and provided impetus to build a comprehensive maternal 
mental health clinic at Kootenai Health. 
Significance of the Doctor of Nursing Practice  
Scholarly Project 
The DNP degree has been promoted by the American Association of Colleges of 
Nursing (AACN, 2006) as the terminal professional nursing degree.  The degree was 
developed in response to recommendations from the Institutes of Medicine (cited in 
Moran, Burson, & Conrad, 2014) reports, Crossing the Quality Chasm and The Future of 
Nursing, both of which identified the need for changes to the structure and 
implementation of healthcare delivery in the United States.  The intended outcome of 
such restructuring was to  
promote health care that is safe, effective, client-centered, timely, efficient, and 
equitable; that health professionals should be educated to deliver patient-centered 
care as members of an interdisciplinary team, emphasizing evidence-based 
practice, quality improvement and informatics; and, that the best prepared senior 
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level nurses should be in key leadership positions and participating in executive 
decisions. (AACN, 2006, pp. 5-6) 
The DNP scholarly project also serves as a demonstration of the student’s ability 
to synthesize evidence and translate it into clinical practice.  Moran et al. (2014) indicated 
that when a student is developing a DNP scholarly project, the following questions 
should be considered: “Is there a contribution to comprehensive quality health care?  Are 
there specific benefits for a group, population, community, or policy?  Does the project 
advance nursing practice at the local, state, and national levels?” (p. 74).   
This DNP scholarly project met the majority of the criteria noted above.  The 
project focused on improving access to evidence-based treatment in a patient-centered 
setting.  Implementation of the project would improve efficiency and promote safety 
while providing clinical benefits to a generally under-served population.  Developing the 
project required this author to assume a leadership position and to work collaboratively 
with other healthcare professionals.  When implemented, the initial impact would be at 
the local community level but if successful, the program would hopefully be adopted 
across the region and neighboring communities.   
Congruence with Organization’s Strategic Plan 
Kootenai Health (2018) is a 292-bed community-owned hospital in Idaho’s 
northern “panhandle.”  It provides services to residents of northern Idaho, eastern 
Washington, and western Montana.  Kootenai Health’s mission is to “improve health one 
patient at a time in a friendly and professional culture committed to superior quality and 
safety” (p. 1).  The organization’s vision is to become “a comprehensive regional medical 
center delivering superior, patient-focused care and [to] be recognized among the premier 
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health care organizations in the United States” by 2020 (Kootenai Health, 2018, p. 1).  
Kootenai Health received the “Baby-Friendly” designation in 2002, which indicates the 
highest standard of care for mothers and babies, and recognizes the organization’s 
dedication to “improving infant health through breastfeeding and other maternal-infant 
care practices” (p. 1).  The hospital opened a Level III NICU in 2016, reiterating their 
commitment to caring for the most vulnerable babies and families. 
In 2006, Kootenai Health (2018) received Magnet status designation from the 
American Nurses Credentialing Center.  This designation is recognized nationally as “the 
gold standard” for nursing excellence; hospitals with this designation are expected to 
promote a collaborative culture that values, supports, and retains nursing talent.   
Support of the development and implementation of this DNP scholarly project 
was congruent with Kootenai Health’s (2018) commitment to providing innovative, 
evidence-based, and patient-centered care as well as supporting the professional 
development of nurses. 
Assumptions 
Prior to and during development of this scholarly project, assumptions were made 
based on direct personal observation, professional clinical experience, and 
communication with stakeholders.  This author became pregnant with her first child 
around the time she was formulating the concept for her scholarly project.  She attended 
her prenatal and postpartum appointments with a provider whom she trusted, wondering 
if she would receive some form of screening for depression or anxiety—she did not.  
When she asked directly, her OB and her nursing staff revealed they believed mental 
health was an under-recognized issue but they felt unprepared to assess, much less 
20 
 
address it.  As this author delved into the literature, she found her experience was fairly 
typical and further discussion with obstetric, pediatric, and mental health providers in her 
community confirmed they felt this was an area in need of much attention.  This author 
recently gave birth to her second child and was encouraged to learn that her OB’s office 
provided some screening (PHQ-2 at initial prenatal visit [Kroenke et al., 2003]; PHQ-9 at 
six-week postpartum visit [Kroenke et al., 2001]) but not surprised to hear that if 
someone scored ‘positive’ on the screens, the offices felt unequipped to manage patients 
or refer them to someone who could.   
As a psychiatric provider in an acute inpatient behavioral health unit, this author 
frequently cared for women experiencing postpartum depression and anxiety (and less 
frequently mania and psychosis) and become frustrated to learn that (a) many of the 
women either had histories of mental illness prior to pregnancy and had either 
independently discontinued their psychotropic medications or had been taken off of 
medications by well-meaning but poorly-informed providers or (b) had not been formally 
diagnosed with mental health issues prior to pregnancy but clearly displayed signs and 
symptoms that could have been addressed earlier, potentially avoiding the need for 
hospitalization.  Finally, this author became acutely aware of the difficulty her unit’s case 
managers had finding appropriate and timely follow up for these women after hospital 
discharge.  Her personal and professional experiences were unfortunately consistent with 
findings from across the country but she was encouraged to see a tremendous amount of 






This project was limited in scope to developing a guide for the screening, referral, 
and follow up of mood and anxiety disorders in women who were cared for prenatally by 
Kootenai OBGYN providers (obstetricians and midwives).  Upon evidence of support or 
interest, the guide could be shared with independent obstetric and midwifery practices in 
the community as well as pediatric and primary care providers.  The scholarly project 
entailed developing the guide and seeking consensus and approval from stakeholders.  
Full implementation of a stepped care or integrated mental health model will occur 
outside the timeframe of the scholarly project as it would involve hiring and onboarding 
one or two clinicians to be embedded within the OB clinic, a process that would require 
significant institutional investment and could take many months.  The guide did not make 
specific treatment recommendations (i.e., recommending specific medications or 
dosages) as doing so would have vastly expanded the scope of the project.  The issue of 
under-recognized bipolar disorder was noted and discussed in the literature review but 
ultimately screening for bipolar disorder was not specifically addressed in the guideline.  
Similarly, separate instruments were not identified to screen for anxiety or psychosis.  It 
was felt initial efforts should focus on building basic infrastructure and screening systems 








CHAPTER II  
LITERATURE REVIEW 
Historical Background of Perinatal Mood  
and Anxiety Disorders 
Disturbances in mood and sensorium in pregnant and postpartum women have 
been described in the literature for more than a thousand years, beginning with 
Hippocrates’ descriptions of “agitation, delirium and attacks of mania” in a woman who 
had recently given birth to twins (Hanley, 2009, p. 3).  Hippocrates (cited in Hanley, 
2009) theorized these attacks were the result of suppressed lochial discharge flowing to 
the head, consistent with his theory that four “humors” determined health and 
temperament and that imbalance of said humors would result in illness.  Modern 
scientists proposed that what Hippocrates described in the postpartum woman was in fact 
Streptococcus A infection leading to sepsis and delirium but the belief that mental 
disturbances in postpartum women resulted from excess moisture endured for centuries.  
The 13th century physician Trotula (cited in Hanley, 2009) wrote: “If the womb is too 
moist, the brain is filled with water, and the moisture running over the eyes compels them 
to involuntarily shed tears” (p. 3). 
 While the belief that women’s psychiatric symptoms were due to fluid imbalance 
was misguided, things only got worse for women in the Middle Ages when various forms 
of mental illness were attributed to the practice of witchcraft and often punished by 
burning or drowning—if the accused did not first die of suicide (Tasca, 2012).  Case 
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studies of postpartum mental disturbances began to emerge in the 16th century.  By the 
mid-19th century, the French physician Jean-Etienne Esquirol compiled 92 detailed case 
reports describing postpartum delirium and melancholy (Hamilton, 1962).  He described 
varying degrees of illness; some were severe, requiring psychiatric hospitalization, and 
others were milder and could be cared for in the home.  He also identified proposed 
causes of the illness including heredity, “extreme susceptibility,” previous similar 
episodes, emotional instability, and traumatic events (Hamilton, 1962, p. 126).  These 
early observations bore striking resemblance to currently recognized risk factors for 
perinatal mental illness.  However, Esquirol’s recommended interventions reflected 
typical medical practice at the time, primarily tepid baths and purgatives (a contemporary 
American psychiatrist also prescribed copious amounts of opium to reduce restlessness 
and irritability; Hamilton, 1962).   
 Later in the 19th century, Louis-Victor Marcé (after whom the Marcé Society was 
named) emerged as an authority on psychiatric illness in the perinatal period (Hamilton, 
1962).  He wrote extensively about more than 300 cases he had observed and categorized 
symptom onset into three periods: during pregnancy, in the “puerperal period” (the first 
six weeks after delivery), and the “lactational period” (more than six weeks postpartum) 
(Hamilton, 1962, p. 128).  His writings described “délére triste” or “sad delirium,” which 
corresponded to what is currently called postpartum psychosis.  Marcé might have been 
the first researcher to propose a biologic basis for perinatal mental health issues, noting 
illness corresponded to physical and functional changes in the female reproductive cycle 
(Hamilton, 1962; Hanley, 2009).  
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 In the 1920s, three main theories arose to describe the etiology of perinatal mental 
health issues (Hamilton, 1962).  The first asserted no mental disorders were unique to 
pregnant and postpartum states; the second attributed psychogenic causes to postpartum 
illness; and the third suggested perinatal mental illness was influenced by physiological 
changes (as Marcé had proposed almost 70 years earlier).  In 1937, Kanosh and Hope 
(cited in Brummelte & Galea, 2016) concluded postpartum psychiatric symptoms were 
related to chemical changes that occurred a few days after birth, consistent with the 
modern observation that abrupt drops in estrogen and progesterone levels after delivery 
might contribute to postpartum psychiatric illness (Brummelte & Galea, 2016). 
 By the 1950s, dysphoria in the days after birth was discussed freely in women’s 
magazines, including Ladies’ Home Journal and McCall’s.  The former published a letter 
from a maternity nurse calling attention to the “cruelty of maternity wards” (Held & 
Rutherford, 2012, p. 112), resulting in a flood of letters from readers confirming their 
own negative experiences.  A phenomenon known as “third day blues” was described as 
resulting from unpleasant birthing experiences in hospitals with inattentive staff, 
unnecessary ‘medicalization’ of the birthing process, and disregard for the mothers’ 
autonomy.  In response, Dr. Frank McGowan responded to rising levels of feminist-
consciousness with an article in McCall’s in which he assured women that brief, mild 
“postnatal blues” were normal and women with more severe symptoms had underlying 
psychological or characterological flaws (Held & Rutherford, 2012).   
 The term “postpartum depression” first appeared in a 1960 issue of Good 
Housekeeping (cited in Held & Rutherford, 2012) with some acknowledgement that if 
depression persisted beyond the first few days after delivery it might warrant professional 
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treatment with newly emerging tranquilizer and antidepressant medications.  A 1968 
study of more than 300 women estimated prevalence of postpartum depression at 10.8% 
(Rhodes & Segre, 2013).  The impacts of PMADs on infants were noticed in the 1970s 
when researchers studying the negative effects of maternal schizophrenia on children 
used depressed mothers as a control group.  To their surprise, similar negative effects 
were noticed in both groups of children including increased risk for cognitive, motor, and 
language delays (Rhodes & Segre, 2013).   
Despite increasing awareness, the DSM did not acknowledge the existence of 
postpartum depression until its 4th edition, which was published in 1994 (Segre & Davis, 
2013).  In that edition, postpartum mood disturbance was not considered a distinct 
category or illness; rather, “postpartum onset” was a specifier that could be added to 
episodes of mania, depression, or psychosis.  This specifier remained in the subsequent 
DSM-IV-Text Revision (DSM-IV-TR) and was modified to include “peripartum onset” 
in the current edition of DSM-5 published in 2013 (Segre & Davis, 2013).    
The early 2000s brought intensely high levels of media coverage to the issues of 
perinatal mental health.  In June 2001, three months after giving birth to her daughter and 
suffering from severe postpartum depression and psychosis, Melanie Stokes jumped to 
her death from the 12th floor of a hotel in Chicago (Postpartum Depression Alliance of 
Illinois, n.d.).  After her death, Melanie’s family became vocal advocates for perinatal 
mental health, eventually lobbying for the Melanie Blocker Stokes MOTHERS Act.  
Signed into law in March 2010, the legislation provides funding and support for research, 
awareness, and treatment of perinatal mental health issues (Postpartum Depression 
Alliance of Illinois, n.d.). 
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The same month Melanie Stokes died, a mother in Houston, Texas, drowned her 
five children in a bathtub in the midst of a postpartum psychotic episode.  The Andrea 
Yates case shocked the nation on multiple levels—first the disbelief that a mother could 
calmly and methodically kill her small children and then the disbelief she could be tried 
and potentially sentenced to death for actions carried out when suffering from a severe 
mental illness (Charatan, Eaton, & Eaton, 2002).  In 2002, Yates was convicted of capital 
murder and sentenced to life in prison (over the objection of the prosecution who 
recommended the death penalty).  The conviction was later overturned and in 2006, 
Yates was acquitted by reason of insanity and committed to a state psychiatric facility 
(McLellan, 2006). 
These highly publicized cases dramatically shifted the public narrative about 
perinatal mental health.  News media ran stories highlighting the prevalence and 
seriousness of postpartum depression while advocates for mental health and criminal 
justice reform aligned to advance awareness and shape legislation (Levin, 2016; Moran, 
2002).  In the mid-2000s, American celebrities began going public with their own mental 
health struggles. One of the first was Brooke Shields who appeared on Oprah in 2005 to 
discuss her battle with postpartum depression and to release her new memoir, Down 
Came the Rain: My Journey Through Postpartum Depression.  In subsequent years, 
Shields was joined by Courtney Cox, Gwyneth Paltrow, Amanda Peet, Drew Barrymore, 
Adelle, and other famous women who shared their experiences with postpartum 
depression.   
As awareness of PMADs has advanced in recent years, and so have advocacy and 
legislation.  In 2006, New Jersey became the first U.S. state to mandate postpartum 
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depression screening; it was soon followed by Illinois, Massachusetts, and West Virginia.  
Many other states have convened task forces to expand education, screening, and access 
to care (Rhodes & Segre, 2013; 2020 Mom, n.d.).  In 2010, the Melanie Blocker Stokes 
MOTHERS Act was included in the text of the U.S. Patient Protection and Affordable 
Care Act (ACA), mandating ongoing research and development of evidence-based 
treatment approaches to PMADs (Postpartum Depression Alliance of Illinois, n.d.).  This 
legislation was unfunded but in 2016 the Bringing Postpartum Depression Out of the 
Shadows Act was signed into law and allocated $5 million to states to develop and 
expand treatment of PMADs (2020 Mom, n.d.).   
In June of 2018, Illinois enacted new legislation that allowed postpartum mental 
illness to be considered as a mitigating factor in criminal sentencing (Prokos, 2018).  
While laws in the United Kingdom and Europe recognize postpartum psychosis is a 
mental illness requiring treatment and rehabilitation rather than incarceration and 
punishment, Illinois’ law is thus far the only one in the United States that acknowledges 
or references perinatal mental illness (Prokos, 2018).  Understanding of perinatal mental 
health issues has progressed immensely since ancient times but there is still much work to 
be done.  Expanding awareness and advocacy must be translated into improved access 
and treatment, which in turn must improve outcomes for women, their babies, and their 
communities.   
Theoretical Framework 
The Stetler (2001) model was initially developed in 1976 and refined in 1994 as a 
practitioner-oriented model to assist individuals and groups to translate research into 
evidence-based practice.  The model emphasized the importance of critical-thinking and 
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acknowledged non-research related forms of information are frequently combined with 
research in the decision-making process.  Use of the model involved “determination of 
the availability of needed resources and, if applicable, the cooperation, support, or 
readiness of the stakeholders” (Stetler, 2001, p. 273).  The Stetler model was used as the 
theoretical framework for this DNP scholarly project because the emphasis on both 
external evidence (formal studies, systematic reviews, consensus of national experts) as 
well as internal factors (experiences, local consensus) allowed a valuable level of 
flexibility and creativity that would facilitate implementation of a new clinical practice 
that matched the needs of the providers as well as the community.  The model consisted 
of the following five phases: 
• Phase I: Preparation 
• Phase II: Validation 
• Phase III: Comparative Evaluation & Decision-Making 
• Phase IV: Translation/Application 
• Phase V: Evaluation 
Phase I: Preparation involved use of “conscious, critical thinking,” (Stetler, 2001, 
p. 275) to identify a problem, define the purpose and outcomes of a project, affirm 
priorities, consider influential factors, and perform initial review of sources of 
information.  For this scholarly project, this phase involved informal discussion with 
stakeholders, general review of related literature, and observation of community trends.  
Stakeholders included local OB, pediatric, and mental health providers; nurse managers; 
social workers; as well as patients who tried to navigate the system with varying degrees 
of success.  This phase overlapped with the author’s first pregnancy, during which time 
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she was increasingly aware of the prevalence of PMADs as well as the dearth of local 
resources available.  This phase involved considering both external and internal factors 
when determining how to obtain and assess information. 
  Phase II: Validation required critical evaluation of sources that would be used in 
project development and implementation and synthesis of those findings.  If sources of 
information were not found to be valid, the process could not continue.  This involved a 
comprehensive literature review and discussion with national experts in the field of 
perinatal mental health.  Additionally, a brief survey was distributed to local stakeholders 
to assess their current practice with regard to PMADs.   
In Phase III: Comparative Evaluation and Decision-Making, this author assessed 
substantiating evidence, fit of the setting, feasibility, and current practice in order to 
guide her decision-making.  While a brief survey was distributed to stakeholders during 
the validation phase, this project used the Delphi method to formally solicit more detailed 
feedback from OB and mental health providers in the community regarding their 
perceived needs, beliefs, and barriers.  A wealth of literature was available regarding the 
assessment, referral, and treatment of PMADs; however, without stakeholder engagement 
and without ensuring a good ‘fit’ for the target community, potential benefits of this 
project would be diminished. 
  In Phase IV: Translation/Application, evidence received in Phase III was 
translated into action.  For this scholarly project, this culminated in the development of a 
guide related to screening, assessment, and referral of PMADs that fit the needs of the 
community (including providers, consumers, and other stakeholders).  This guide took 
30 
 
into account current clinical practice, workflows, perceived needs of the users, and 
available community resources. 
  According to Stetler (2001), Phase V: Evaluation could be formal or informal and 
focused on an individual or an institution.  Evaluation of the effects of the guide will 
occur outside the scope of this scholarly project and will involve discussion with 
administration, providers, and staff, as well as chart audit and case review.  Individual 
impacts will be assessed through face-to-face discussion with stakeholders to gather 
feedback to make ongoing refinements to the guide.   
Synthesis of the Literature 
An extensive and reiterative review of literature was conducted prior to and 
during development of this scholarly project.  The review focused on three primary 
domains: (a) a review of position statements, best practices, and formal recommendations 
for screening and treatment of PMADs issued by pertinent organizations (American 
College of Obstetricians and Gynecologists, American Academy of Pediatrics, American 
Academy of Family Physicians, U.S. Preventive Services Task Force, American 
Psychiatric Association, and others); (b) a review of exemplar guidelines, algorithms, and 
“toolkits” for screening and treatment of PMADs actually used in clinical practice around 
the country; and (c) a review of evidence supporting the recommendations and current 
practices. 
The literature search included use of PubMed, Cumulative Index to nursing and 
Allied Health Literature (CINAHL), GoogleScholar, the Agency for Healthcare Research 
and Quality’s National Guideline Clearinghouse, and individual organizations’ webpages.  
Keywords included perinatal, pregnancy, postpartum, depression, anxiety, mood disorder, 
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psychosis, mental health, screening, treatment, referral, system, guideline, algorithm, 
toolkit, referral, and system. 
Professional Organization Recommendation: 
American College of Obstetricians  
and Gynecologists 
In a committee opinion published in May, 2015 (reaffirmed in 2016 and updated 
in 2018), the American College of Obstetricians and Gynecologists (ACOG) 
recommended that “clinicians screen patients at least once during the perinatal period for 
depression and anxiety symptoms using a standardized, validated tool” (p. e208).  The 
opinion noted perinatal depression and anxiety were among the most common 
complications of pregnancy and if untreated could have significant negative impacts on 
women, their infants, and their families.  The ACOG opinion noted that identifying 
women during the perinatal period might help to mitigate potentially devastating effects: 
“There is evidence that screening alone can have clinical benefits, although initiation of 
treatment or referral to mental health care providers offers maximum benefit” (p. e208).1  
The committee advised that OB providers and clinical staff be poised to initiate treatment 
and refer the patient to appropriate behavioral health resources if indicated.  These 
resources were not described and the opinion simply stated, “Systems should be in place 
to ensure follow-up for diagnosis and treatment” (ACOG, 2018, p. e208).   
In 2018, ACOG published a “Postpartum Toolkit,” developed by a task force 
dedicated to “redefining the concept of the postpartum visit by reevaluating the timing 
 
1 The November 2018 update to the ACOG recommendation cited meta-analyses 
commissioned by the USPSTF (O’Connor, Rossom, Henninger, Groom, & Burda, 2016; 
Siu, 2016) as evidence that screening alone might improve outcomes; however, in-depth 
review of those documents in fact indicated there was no evidence that screening alone 
improved outcomes.  The authors specifically noted these studies did not separate women 
who received screening alone from women who received treatment and screening.  
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and content of postpartum care” (p. 1).  This toolkit included information, 
recommendations, and resources focused on improving the quality and 
comprehensiveness of postpartum care across multiple domains including pregnancy 
complications, preventative care, vaccinations, weight management, reproductive 
planning, substance use, breastfeeding, and depression.  A section on postpartum 
depression discussed incidence, risk factors, signs and symptoms, screening instruments, 
treatment, and referral resources.   
Screening timing and interval.  The ACOG (2016) opinion was relatively vague 
in terms of when screening should be completed, specifying only “at least once during 
the perinatal period” (p. 1).  This period included pregnancy and the first 12 months 
postpartum.  The opinion noted that if a woman screened positive for depression or 
anxiety during pregnancy, additional screening should be completed during the 
comprehensive postpartum visit.  The postpartum toolkit (ACOG, 2018) did not make 
any specific recommendations regarding depression screening intervals but generally 
recommended all postpartum women see their providers within three weeks after delivery 
and again no later than 12 weeks postpartum.   
Screening tools.  The ACOG (2016) opinion did not specifically endorse use of 
any one screening tool but outlined the pros and cons of several tools that had been 
validated for use during pregnancy.  The opinion listed seven tools: the Edinburgh 
Postnatal Depression Screen (EPDS), Postpartum Depression Screening Scale (PDSS), 
PHQ-9, and several others (ACOG, 2016).  The EPDS was discussed most extensively 
and was recommended over the other tools in part because it assessed anxiety and 
excluded somatic symptoms that are normal in the postpartum period.  It was noted the 
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screening tools were not diagnostic and results must be interpreted with clinical judgment 
and consideration to context.   
In the ACOG (2018) toolkit under the subheading “Screening and Diagnosis,” 
seven different screening instruments were listed in bullet-point format (including the 
EPDS, PDSS, and PHQ-9, Beck Depression Inventory I and II, and others).   
Beyond screening.  In the original 2015 opinion and the 2016 revision, ACOG 
acknowledged that screening alone would not improve clinical outcomes and must be 
paired with appropriate treatment and follow up.  This might include initiation of medical 
therapy by the OB provider and/or referral to other appropriate resources.  The use of 
collaborative care, including use of a “depression care manager,” (suggested to be a nurse 
or social worker) possibly even within the OB office, is suggested, though no further 
guidance is issued in the committee opinion.  
In the postpartum toolkit (ACOG, 2018), the subheading “Treatment” lists peer 
counseling, cognitive behavioral therapy, and antidepressants, and the subheading 
“Anticipatory Guidance and Follow-up” recommends encouragement, support, and 
referral to a behavioral health specialist in cases of suicidal ideation, severe symptoms, or 
bipolar disorder.  As of February, 2018, the toolkit echoed the previous ACOG (2016) 
committee opinion that screening alone did not improve clinical outcomes and it was 
imperative that providers promptly refer patients to appropriate mental health resources 




U.S. Preventive Services Task Force 
Recommendation Statement:  
Screening for Depression  
in Adults  
In 2016, the USPSTF (Siu, 2016) published an updated statement on screening for 
depression in adults, recommending “screening for depression in the general adult 
population, including pregnant and postpartum women.  …Screening should be 
implemented with adequate systems in place to ensure accurate diagnosis, effective 
treatment, and appropriate follow-up” (p. 380).  Convincing evidence indicated screening 
improved identification of depression in primary care settings and subsequent treatment 
with psychotherapy, antidepressants, or a combination of both improved clinical 
outcomes.  The USPSTF’s review of fair or good quality trials found 28%-59% 
reductions in risk of depression in postpartum women who received screening and some 
form of follow-up as compared to care-as-usual (Siu, 2016).  
Adequate evidence was found that the magnitude of harms for screening of 
depression across the adult population was small to none (Siu, 2016).  The magnitude of 
harms for treatment of depression in pregnant and postpartum women with cognitive 
behavioral therapy was small to none and the magnitude of harms related to treatment 
with second-generation antidepressants in this population was determined to be small to 
moderate, taking into consideration the low, but potential risk of fetal harm from 
medications (Siu, 2016, p. 381).  The recommendation was rated as Level B, with a level 
of certainty regarding net benefit rated as “moderate.”  The USPSTF (Siu, 2016) 
concluded there was a moderate net benefit to screening for depression in adults, 
including pregnant and postpartum women if there were “adequate systems in place to 
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ensure accurate diagnosis, effective treatment, and appropriate follow-up after screening” 
(Siu, 2016, p. 381).  
Screening timing and interval.  The USPSTF (Siu, 2016) recommendation noted 
limited information was available regarding the optimal timing and frequency of 
screening for depression in pregnant and postpartum women.  In light of limited 
evidence, it was recommended to use a “pragmatic approach,” to consider screening all 
adults who have not been previously screened, and to use clinical judgment to screen 
individuals with risk factors or presentations that raise suspicion of depressive disorders 
(Siu, 2016, p. 382).  
Screening tools.  The USPSTF (Siu, 2016) did not specifically recommend any 
one screening tool but identified the EPDS as a commonly used and validated instrument 
for screening pregnant and postpartum women.  The USPSTF reviewed 23 studies of the 
accuracy of the EPDS and found sensitivity ranging from 0.67 (95% CI, 0.18-0.96) to 
1.00 (95% CI, 0.67-1.00).  Specificity for detecting major depressive disorder (MDD) 
across the studies was at least 0.90 (Siu, 2016, p. 384).  
Beyond screening.  The USPSTF (Siu, 2016) specifically recommended that 
“screening should be implemented with adequate systems in place to ensure accurate 
diagnosis, effective treatment, and appropriate follow-up”; the statement expanded on 
this recommendation, specifying the “appropriate systems and clinical staff must ensure 
(1) screening is conducted; (2) if screens are positive, patients are either appropriately 
diagnosed and treated in that clinical setting, or referred to the appropriate setting for 
follow-up” (p. 383).  The USPSTF recommendation acknowledged these systems could 
take a variety of forms.  The lowest effective level of support was described as a system in 
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which a designated nurse advised physicians of positive screen results and implemented a 
protocol to refer the patient to appropriate follow-up.  The other end of the spectrum, the 
highest level of support involved providing educational workshops to clinical and support 
staff, providing ongoing monthly educational lectures, clinician manuals, printed 
educational materials for providers, staff, and patients; personalized visits with a nurse 
specialist in which the patient receives assessment, education, and ongoing support; and 
visits with a therapist trained in cognitive behavioral therapy (Siu, 2016, p. 383).   
Recommendation Statement: 
American Academy of  
Pediatrics 
The AAP (Earls, 2010) recognized that perinatal depression was “the most 
underdiagnosed obstetric complication in America” (p. 1032) and pediatric providers 
were ideally positioned to facilitate early detection and intervention that could minimize 
negative outcomes for the infant, mother, and family unit.  In 2010, the AAP published a 
clinical report entitled, Incorporating Recognition and Management of Perinatal and 
Postpartum Depression into Pediatric Practice (Earls, 2010).  The report offered a 
review of pertinent literature and made recommendations regarding screening, treatment, 
and referral of perinatal depression.  The report also specified which current procedural 
terminology (CPT) code should be used for screening to facilitate reimbursement.  The 
recommendations were drawn largely from the Surgeon General’s Conference of 
Children’s Mental Health report (U.S. Department of Health and Human Services, 2000), 
USPSTF recommendations (Siu, 2016), and the AAP’s own Bright Futures guidelines, 
which provided a suggested schedule of screenings for preventive pediatric health care 
(Earls, 2010).  
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The AAP report (Earls, 2010) recognized that while the infant, not the mother, 
was the pediatric provider’s patient, supporting the mother and ensuring timely 
assessment and referral to appropriate resources would positively impact the entire family 
system.  Because the pediatric care provider might have the most regular and frequent 
contact with the mother/family after birth, they were in an optimal position to provide 
early screening and facilitate intervention (Earls, 2010).   
Screening timing and interval.  The AAP (Earls, 2010) recommended screening 
at the one-, two-, four-, and six-month visits based on statistical peaks in onset of 
postpartum depression at six weeks, two to three months, and six months after 
delivery.  Screening was not specifically recommended at a prenatal visit but the report 
noted this could be an ideal opportunity to identify risk factors and anticipate care 
needs.  The report recommended using CPT code 99420 for screening, indicating this 
assessed a measure of risk in the child’s environment.  This CPT code has since been 
deleted and replaced with code 96161, indicating “administration of caregiver-focused 
health risk assessment instrument (e.g., depression inventory) for the benefit of the 
patient, with scoring and documentation, per standardized instrument” (AAP News, 
2016).  
Screening tools.  The AAP (Earls, 2010) recommended using either the EPDS 
(Mcbride et al., 2014) or the PHQ-2 (Kroenke et al., 2003).  It should be noted the AAP 
report was published in 2010 and based on the USPSTF 2002 depression screening 
recommendations, which have since been updated and specifically recommend use of the 
EPDS in perinatal women and the PHQ (various forms) in the general adult population 
(USPSTF, 2018).   
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Beyond screening.  The AAP (Earls, 2010) recognized symptoms and illness 
exist on a continuum and responses to positive screens should be appropriately tailored to 
the individual and situation.  Reassurance and education might be the most appropriate 
response to milder symptoms, whereas moderate or severe symptoms might require 
referral to another provider including obstetric, primary care, or mental health 
providers.  If there was any indication of psychosis or suicidality or if the EPDS (Mcbride 
et al., 2014) score was greater than 20, the AAP recommended “using the referral process 
for local public mental health crisis/emergency services” (Earls, 2010, p. 1036).  The 
report recommended considering referral to a variety of community-based programs 
including Early Head Start, Mother’s Morning Out, or the Nurse-Family Partnership.  No 
guidance was provided regarding use of psychotropic medications or specific forms of 
psychotherapy.  
Recommendation Statement: 
Postpartum Support  
International 
Postpartum Support International (PSI, 2019a) is an organization founded in 1987 
with the purpose of increasing “awareness among public and professional communities 
about the emotional changes that women experience during pregnancy and postpartum” 
(p. 1).  The organization advocates for research and legislation to support perinatal 
mental health and provides printed and electronic educational materials, online support 
groups, a toll-free warm-line, and comprehensive training for health systems, support 
group leaders, clinicians, and volunteers.  Postpartum Support International maintains a 
section on their website with up-to-date recommendations for screening, treatment, and 
referral of PMADs.   
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Screening timing and interval.  Postpartum Support International (2019b) 
recommends screening (a) at the first prenatal visit, (b) at least once in the second 
trimester, (c) at least once in the third trimester, (d) at the first or the six-week postpartum 
OB visit, and (e) at 6- or 12- months postpartum either in the OB or primary care 
settings.  Additionally, PSI recommends screening be performed at the 3-, 9-, and 12-
month pediatric visits. 
Screening tools.  Postpartum Support International (2019b) recommends use of 
the EPDS (Mcbride et al., 2014) or the PHQ-9 (Kroenke et al., 2001) with 10 being a 
recommended cut-off score for a positive screen using either tool.  Postpartum Support 
International also notes the EPDS is a reliable screening tool for fathers but requires a 
lower cut-off for a positive score (recommended to use 5 or 6 to determine a ‘positive 
screen’).  It is recommended the screening be provided in the patient’s native language if 
possible, in a private setting, and be introduced in a “caring and informative manner that 
normalizes perinatal mental health needs” (PSI, 2019a, p. 1).   
Beyond screening.  Postpartum Support International’s (2019b) 
recommendations note that screening must be performed within a system that provides 
appropriate providers, supports, and an established protocol for referral for follow-
up.  The organization actively supports such systems by providing education to patients 
and clinicians, maintaining provider directories to facilitate referrals, and advocating for 




Recommendation Statement: Department  
of Veteran Affairs/Department  
of Defense 
The Department of Veteran Affairs and Department of Defense (Veterans Affairs, 
2016) published an updated clinical practice guideline for management of pregnancy in 
2018.  New to this update (since 2009) is the recommendation that pregnant women be 
screened for depression during pregnancy and postpartum.  This guideline was accessed 
through the Agency for Healthcare Research and Quality (2018), which has scored the 
guideline as “excellent.” 
Screening timing and interval.  According to the VA/DoD guideline, screening 
for depression was recommended “periodically during pregnancy and postpartum” 
(Veterans Affairs, 2016, p. 21).  No further recommendations were given regarding 
timing for frequency.     
Screening tools.  The VA/DoD (Veterans Affairs, 2016) guideline recommended 
using the EPDS (Mcbride et al., 2014) or PHQ-9 (Kroenke et al., 2001). 
Beyond screening.  There was no discussion in the VA/DoD (Veterans Affairs, 
2016) guideline about further evaluation, referral, or treatment of depression in pregnant 
or postpartum women.  Potential harms of screening included time spent screening and 
possible discomfort with screening questions.  
Recommendation Statement: Marcé  
Society for Perinatal  
Mental Health 
The Marcé Society (2019) was formed in England in 1980 and its stated aim was 
to “promote, facilitate and communicate about research into all aspects of the mental 
health of women, their infants and partners around the time of childbirth” (para. 2).  In 
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2013, the Society published a position statement on psychosocial assessment and 
depression screening in perinatal women that discussed arguments for and against 
universal psychosocial assessment and depression screening (Austin, 2014).  The 
statement outlined general principles involved in this work but explicitly avoided making 
specific recommendations regarding tools, instruments, or systems to facilitate such 
screening, instead stating, “These will need to be devised locally depending on existing 
resources and models of care” (Austin, 2014, p. 179).   The position statement included a 
bullet-pointed list of “Guiding Principles” and suggested these be considered when 
providing psychosocial assessment and depression screening.  These were fairly broad, 
non-specific recommendations (Austin, 2014). 
Screening timing and interval.  The Marcé Society’s position statement 
suggested screening be completed during pregnancy and “at an appropriate time 
postpartum (e.g., 3 months)” (Austin, 2014, p. 185).  No further or more specific 
recommendations were made. 
Screening tools.  The Marcé Society (Austin, 2014) did not endorse use of any 
one screening tool or instrument.  The EPDS (Mcbride et al., 2014) was briefly 
mentioned and the statement noted Australian guidelines recommended universal use of 
the EPDS within integrated screening programs.  Scottish and British guidelines 
suggested the EPDS be used only as an adjunct to clinical practice and also mentioned 
use of the Whooley Questions—a two-question depression-screening tool very similar to 
the PHQ-2 (Austin, 2014).  
Beyond screening.  The Marcé Society (Austin, 2014) emphasized the 
importance of psychosocial assessment that involved evaluating multiple domains, which 
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could impact a woman’s mental health including social, cultural, psychological, and 
biological risk factors.  Such assessment is generally completed through clinical 
interview and, in addition to identifying risk factors, could serve as a way of establishing 
a trusting relationship between the woman and her provider and providing an opportunity 
for education (Austin, 2014).  
  The Marcé Society’s (Austin, 2014) position statement emphasized a 
collaboration between providers and professions to improve care with appropriate referral 
by the primary care provider to a specialist when indicated.  These systems should take 
the mothers’ preferences into consideration and respect her personal and cultural needs 
(Austin, 2014).  Table 1 provides more information regarding professional organization 
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Established Protocols/Systems for Screening,  
Referral, Treatment, and Follow Up 
Through the literature review process, several protocols and algorithms pertaining 
to screening, referral, and treatment of PMADs were identified.  Algorithms were 
included for review if they met the following criteria: included specific recommendations 
for which screening tool to use and when to perform screening, included cut-off values 
for ‘positive’ screens, and outlined specific steps for referral based on scores.  This was 
not an exhaustive review of protocols; some identified were similar to the ones detailed in 
the following paragraphs.  The protocols reviewed were chosen for inclusion in this 
literature review because they are comprehensive and innovative, are widely utilized, and 
are supported by research, respectively. 
University of North Carolina  
School of Medicine  
The University of North Carolina (UNC, 2016) has developed one of the few 
inpatient perinatal psychiatry units in the United States.  In addition to the inpatient 
program, the Department of Psychiatry offers a Perinatal Mood Disorders Clinic 
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(PMDC), offering outpatient treatment including psychotherapy, medication 
management, and a perinatal support group.  The program’s founders developed a 
comprehensive perinatal depression screening and treatment algorithm that is used 
throughout the University’s healthcare system.  
Overview of process.  Screening is performed at initial OB, prenatal 28-32 
weeks, lactation problem, and postpartum visits (UNC, 2016).  A nurse or medical 
assistant gives the patient a paper copy of the EPDS (Mcbride et al., 2014) in the 
appropriate language and the patient fills it out independently.  The nurse or medical 
assistant then enters the patient’s responses into an EPDS flowsheet in the EPIC 
electronic medical record (EMR), and the provider then reviews these answers, follows 
up on any positive answers, and assesses the patient for safety (with special attention to 
question #10, which asks about thoughts of self-harm).  Subsequent actions are 
determined by the EPDS score in conjunction with clinical judgment.  All EPDS scores, 
assessments, and treatment plans are documented in the EMR (UNC, 2016). 
Scoring and follow-up.  Scores of =<6 generally prompt supportive counseling 
and encouragement to reach out to the provider should symptoms change.  For scores of 
6-9, the recommendation is to follow up at future visits, repeat EPDS screening if there is 
any indication of symptoms, and to provide printed material about the PMDC (UNC, 
2016). 
Scores of 10-12 indicate concern for minor depression and the provider is 
prompted to discuss stress relief, coping strategies, self-care, and sleep hygiene (UNC, 
2016).  An ICD9 code of 648.4 (“elevated EPDS”) is added to the patient’s problem list 
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(WHO, 2018).  The patient is provided with printed material about the PMDC and follow 
up is conducted at future visits with repeat EPDS if there is any indication of symptoms. 
Scores of =>12 indicate concern for major depression and further clinical 
assessment is indicated (UNC, 2016).  If, after discussion, the clinician is not alarmed 
about the patient’s psychiatric situation or if there is no intent or plan for self-harm, the 
patient is offered counseling, medications, and referral for outpatient psychiatric 
evaluation.  The patient is also provided with the interventions provided for patient with 
scores of 10-12. 
If the clinician IS alarmed by the patient’s presentation or if there is any intent or 
plan for self-harm, the clinician pages one of the PMDC psychiatric providers 
(psychiatrists or psychiatric nurse practitioners) to discuss a plan of care (UNC, 2016).  If 
there is concern for immediate harm to self or others, the patient is escorted to the nearest 
emergency department for evaluation.  
Massachusetts Child Psychiatry  
Access Project  
The Massachusetts Child Psychiatry Access Project (MCPAP, 2015) is a network 
of behavioral health consultation teams that provides support to primary care providers 
and facilitates integration of behavioral health into the primary care setting.  The MCPAP 
developed a downloadable toolkit, the MCPAP for Moms Toolkit, to help providers 
implement screening into their pediatric visits as well as provide education, prompts, and 
suggestions for providers.  Included in the toolkit are a primer with background 
information about the prevalence, risk, and potential complications of PMADs as well as 
available treatment options, a screening algorithm with suggested talking points, PDFs of 
the EPDS (Mcbride et al., 2014) and PHQ-9 (Kroenke et al., 2001), and PDFs of 
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checklists that incorporate EPDS questions into comprehensive well-child assessments 
for specific age groups (MCPAP, 2015).  The toolkit also includes a handout with clinical 
pearls that can help a provider assess levels of risk and a summary of PMADs including 
Baby Blues, perinatal anxiety, perinatal depression, PTSD, OCD, and postpartum 
psychosis.  Finally, the toolkit provides information about resources available in 
Massachusetts including emergency services, expedited referral to mental health 
providers, and home visitation programs (MCPAP, 2015). 
Overview of process.  Postpartum depression screening is completed during 
well-child visits within the first month after birth, at the two-, four-, and six-month visits, 
and at other visits if indicated (MCPAP, 2015).  The recommended screening tool is the 
Survey of Wellbeing of Young Children (SWYC; Tufts Medical Center, 2019), which is 
described as “a comprehensive screening instrument used to assess children’s cognitive, 
language, motor, and social-emotional development as well as family risk factors” (para. 
1).  The SWYC is provided in versions specifically tailored to the two-, four-, and six-
month visits with the original EPDS (Mcbride et al., 2014) embedded in each version.  
  Clinical support staff explains the screen to the parent at the time of the first 
screening, and the parent self-completes the SWYC in a waiting room or private exam 
room.  The MCAPA toolkit instructs the provider to document a clinical plan based on 
screening results but notes the screen itself is not required to be included as part of the 
medical record.  The provider might bill for screening (using the SWYC with embedded 
EPDS [Mcbride et al., 2014], or the standalone EPDS) using the developmental-
behavioral procedure code 96110 (WHO, 2018). 
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Scoring and follow-up.  An EPDS (Mcbride et al., 2014) score of <10 is 
considered to not suggest depression, and clinical staff provide the parent with 
information about community resources to support emotional wellness (MCPAP, 2015).  
An EPDS score of ≥10 is considered to be a positive screen and further steps are based on 
clinical assessments of safety and risk.  If there is any indicated risk of self-harm or 
suicide, immediate further assessment is indicated; talking points and assessment 
questions are provided in the screening algorithm.  The parent/baby are not to be left 
unattended until further assessment and treatment plans have been established.  The 
provider is instructed to call the MCPAP (2015) regional hub with any clinical questions 
and to refer to emergency services for any safety concerns. 
For positive screens without concern for self-harm or suicide and if the patient is 
currently or previously engaged in mental health treatment, they should be referred back 
to their mental health provider and the provider should be notified of the positive screen 
(with the patient’s consent).  If the parent is not already engaged in mental health 
treatment, the provider can contact a MCPAP for Moms care coordinator for community 
referral resources and referral information.  The parent’s primary care provider (PCP) 
and/or OBGYN should also be notified of the need for monitoring and follow-up.  
Throughout this process, the pediatric provider can provide the parent with supportive 
counseling and encouragement (MCPAP, 2015).  
The Women’s Place-Texas  
Children’s Hospital 
The Women’s Place is reproductive psychiatry program at the Texas Children’s 
Hospital (affiliated with Baylor College of Medicine) in Houston, Texas, that provides 
psychiatric and psychological services for women across the reproductive lifespan 
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including preconception, during pregnancy, postpartum, and through menopause 
(Puryear, 2018).  The program has recognized the need for enhanced detection, referral, 
and treatment of perinatal mental health issues in primary care, noting there are not 
enough mental health specialists to treat all those who need help.  The program also notes 
that while screening recommendations and legislation are an important first step, it is 
imperative that appropriate systems be developed for follow-up, treatment, and ongoing 
support in the community.  Using funding provided through the Texas Delivery System 
Reform Incentive Payment program, researchers and providers at The Women’s Place 
developed a pilot project with the goal to increase access and improve the early detection 
and treatment of perinatal mental health (Puryear, 2018).  The team surveyed primary 
care providers (pediatric and OB) and found common barriers to screening and 
assessment of perinatal mental health issues included lack of adequate mental health 
referral destinations, fear that screening meant ‘ownership’ of the problem, and lack of 
time and reimbursement.  Additional challenges faced by pediatric providers included 
overcoming new mothers’ fear of Child Protective Services (CPS) involvement should 
she disclose any symptoms of mental illness or thoughts of harming herself or her baby 
(Puryear, 2018). 
Through this pilot program, The Women’s Place team provided one-hour 
trainings to providers and clinical staff in pediatric and OB practices focused on the signs 
and symptoms of PMADs, administration and scoring of the EPDS, and documentation 
and submission of electronic referrals through the electronic medical record (Puryear, 
2018).  The team provided ongoing consultation, education, and support for the pediatric 
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and OB providers as well as analysis of rates of screening, referrals, and completed 
follow-ups.  
Of very high interest, data analysis showed significant differences in follow-up 
completion depending on the location of the mental health provider (Puryear, 2018).  In 
“coordinated referral” or referral to a mental health provider in a separate, distinct 
location, the rate of completed appointments was only 21.1% (Puryear, 2018).  When 
mental health services were co-located (affiliated with the primary care office, within the 
same building or floor but in a separate office), the completion rate was 75.7% and when 
mental health was coordinated (an embedded provider within the primary care office), the 
completion rate was 81.1% (Puryear, 2018). 
Overview of process.  The OB providers performed depression screening during 
pregnancy at the first prenatal visit, between 34-36 weeks gestation, and at six weeks 
postpartum (Puryear, 2018).  Pediatric providers performed screening at the initial well-
child visit around two weeks, and two-, four-, and six-month well-child visits.  In both 
settings, the mother self-completed the EPDS (Mcbride et al., 2014), which was scored 
by staff.  Scores and treatment plans ere documented electronically in the EPIC EMR 
(Puryear, 2018).  
Scoring and follow-up.  If a score was =>10, the physician was to be notified and 
would discuss the results, referral, and treatment options with the mother (Puryear, 
2018).  If the mother agreed to the referral, an electronic referral was sent to The 
Women’s Place or another appropriate resource.  If the mother did not agree to the 
referral, this was documented in EPIC.  There was no specific process for ongoing 
follow-up or assessment outlined in the High-Level Process Map detailing the screening 
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and referral process but during a conference presentation of this initiative, the importance 
of an integrated, comprehensive care network was emphasized (Puryear, 2018).  Such a 
system would include culturally appropriate interventions, peer support, social work, 
emergency services, home visit, phone outreach, and a mobile van/clinic that could 
provide services in a woman’s community.  Table 2 provides detailed information 
regarding the aforementioned clinical protocols for assessment and referrals of patients 
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Evidence for Perinatal Mood and  
Anxiety Disorders Screening 
Conflicting evidence exists related to universal screening for depression in 
pregnant and postpartum women.  A systematic review completed by Thombs et al. 
(2014) concluded, “There is currently no evidence from any well-designed and conducted 
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[randomized control trial] that screening for depression would benefit women in 
pregnancy or postpartum” (p. 433).  The authors recommended current screening 
guidelines be reconsidered until quality, randomized control trials could be completed.  
They further recommended healthcare providers educate women and their families about 
depression and that providers be alert for signs or symptoms of depression in pregnant or 
postpartum women and provide appropriate “assessment, […] referral or management” 
(Thombs et al., 2014, p. 439).  
In their recent systematic review of evidence around screening for perinatal mood 
and anxiety disorders, Long, Cramer, Jenkins, Bennington, and Paulson (2018) asserted 
providers too often relied on clinical judgment rather than standardized assessment, 
which could lead to under-recognition of potentially serious illness.  They recommended, 
“Given the prevalence and negative impacts of PMAD on mothers and children, further 
interventions to improve screening and referral are needed” (Long et al., 2018, p. 25).   
A USPSTF commissioned systematic review of evidence published in 2016 by 
Siu found sufficient evidence to support universal screening of pregnant and postpartum 
women.  The systematic review found 28-59% reductions in risk of depression at the 
three- to five-month follow up in women who participated in screening programs.  
However, the study did not differentiate between studies in which women received 
screening alone versus screening and additional treatment (Siu, 2016).   
In January of 2019, a group of researchers in Canada conducted a systematic 
review to evaluate the evidence around screening for depression in pregnant and 
postpartum women but it was unknown when this study would be completed (Hamel et 
al., 2019).  In light of the limited and sometimes conflicting data, it might be appropriate 
53 
 
to take a more pragmatic approach when considering whether or not it is appropriate to 
screen pregnant and postpartum women for PMADs.  Milgrom and Gemmill (2014) 
suggested, “If a health condition is serious, prevalent, under-detected and treatable, and if 
a tolerable screening procedure of known accuracy is available, then screening can be an 
effective measure in principle” (p. 14).  In the case of perinatal mental health issues, these 
five criteria are satisfied.   
Seriousness 
Perinatal mood and anxiety disorders have been associated with significant 
morbidity and mortality.  In the United States, postpartum women are more like to die 
from suicide than from either hemorrhage or hypertensive disorders (Palladino et al., 
2011).  Grigoriadis et al. (2017) found at least 1 in 19 maternal deaths in Ontario, Canada 
were attributable to suicide and it was noted that the actual incidence might be 
significantly higher due to underreporting of postpartum status on death certificates.  
Even when the outcome is not death, PMADs severely impact the mother, infant, partner, 
extended family, and community.  Women are at risk for poor self-care, preterm delivery, 
feelings of shame and worthlessness, and suicide (Hanley & Oberlander, 2014).  Infants 
are at risk for complications including low birth weight, difficulty with sleep, and 
cognitive deficits that might persist into adolescence or beyond (Glover, 2014).  Un- and 
undertreated PMADs might interfere with the mother’s ability to form a healthy 
relationship with her new baby and to maintain relationships with partners and family 






Estimates of the prevalence of postpartum depression have ranged from 7.2% to 
19.2% (Gavin et al., 2005; O’Hara & Wisner, 2014) and depression during pregnancy is 
estimated to be almost as common.  Clinically significant anxiety affects up to 15% of 
pregnant and postpartum women (Paschetta et al., 2014) and up to 43% of women in 
high-risk groups might experience PTSD symptoms (Khoramroudi, 2018).  Merrill et al. 
(2015) commented the background prevalence of bipolar disorder in perinatal women (2-
6%) is similar to that of gestational diabetes (5%) and gestational hypertension (4.4%), 
for which both are routinely screened.  Up to 70% of women with BD experience 
perinatal depressive symptoms (Merrill et al., 2015) 
Under-Detected 
Many experts believe the numbers above might be artificially low as many 
women experiencing PMADs do not independently seek treatment (Milgrom & Gemmill, 
2014).  Beck and Gable (2001) and Cox et al. (2016) estimated up to 50% of all cases of 
perinatal depression go undetected and approximately 85% of affected women do not 
receive treatment.  Furthermore, it was estimated only 3-5% of affected received 
adequate treatment that resulted in symptom remission (Cox et al., 2016).  Barriers to 
detection included lack of awareness about PMADS and available treatment, stigma, 
unrealistic expectations about parenting roles and fear of being perceived as a failure, and 
lack of appropriate resources or ability to navigate the mental healthcare system.  The 
neurogevative symptoms of PMADs including anergia, avolition, impaired concentration, 
and low self-worth can feel insurmountable and can interfere with a woman’s ability to 




Extensive literature supports the effectiveness of pharmacological and non-
pharmacological interventions for PMADs.  Cognitive behavioral therapy, supportive 
psychotherapy, brief dynamic psychotherapy, and interpersonal therapy were identified 
as effective modalities (Cox et al., 2016).   
Evidence for Screening Tools 
The screening tools most commonly used in perinatal women include the EPDS 
(Mcbride et al., 2014), the PDSS (Tatano Beck & Gable, 2002) and the PHQ-9 (Kroenke 
et al., 2001).  Each has been validated to some degree for use in the perinatal population; 
provider or organizational preference might largely influence their use in clinical 
practice.  The Mood Disorder Questionnaire (MDQ; Hirschfeld, 2002) is widely used to 
screen for BD in the general population and in recent years, evidence has emerged 
supporting its use in perinatal women.  The tools are described followed by a review of 
the literature pertaining to their use. 
Edinburgh Postnatal Depression  
Screen 
The EPDS (Mcbride et al., 2014) is one of the most broadly used, most widely 
validated screening tools for depression in the perinatal period.  This brief, self-
administered screen was developed in 1987 by researchers in Scotland who recognized 
that existing depression screening scales did not adequately assess depression in 
postpartum women (Mcbride et al., 2014).  The primary deficit in existing depression-
screening scales was they included somatic symptoms that could suggest depression in 
the regular population but occurred naturally and non-pathologically in postpartum 
women (i.e., changes in sleep or appetite).  Additionally, the existing scales were rather 
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extensive and time-consuming, whereas the EPDS could be completed and scored in 
approximately five minutes and scoring did not require specialized training in mental 
health issues.  The EPDS was developed by integrating questions selected from existing 
scales (the Irritability Depression and Anxiety Scale, the Hospital Anxiety and 
Depression Scale, and the Anxiety and Depression Scale of Bedford and Foulds) with 
questions developed specifically by Mcbride et al. (2014).  Extensive testing on mothers 
with young babies helped refine the scale into a 10-item, self-administered scale that has 
been widely validated for assessment of postpartum and antenatal depression (Mcbride et 
al., 2014).  
The EPDS (Mcbride et al., 2014) consists of 10 items in which subjects are asked 
to rate their symptoms in the previous seven days on a scale of 0-3 (0 = Not at all, 1 = 
Not very often, 2 = Most of the time, 3 = All of the time).  Questions are related to 
emotional symptoms and specifically exclude somatic symptoms common to many 
women in the perinatal period (changes in sleep or appetite).  The 10th item specifically 
asks about self-harm thoughts.  The most commonly used value for a positive screen is 
≥13.  However, some sources recommend using scores of ≥ 9 for enhanced sensitivity, 
arguing that given the potentially detrimental effect of missing cases of perinatal 
depression, false positives are preferable to false negatives.  Any value > 0 on item 10 
(self-harm thoughts) was considered a positive screen and required rapid intervention.  
Using a cutoff score of 13, a USPSTF systematic review by O’Connor et al. (2016) found 
sensitivity of the English-language ranged from 0.67 (95% CI, 0.18-0.96) to 1.00 (95% 
CI, 0.67-1.00).  The same systematic review found specificity to be 0.87 across all 
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reviewed studies.  The EPDS is available for free and published in more than 35 
languages at a third to sixth grade reading level.   
Items 3, 4, and 5 on the EPDS (known collectively as the EPDS anxiety subscale 
or EPDS-3a, Mcbride et al., 2014) inquired about symptoms associated with anxiety 
(blaming oneself, feeling anxious or worried, scared or panicky).  Some studies validated 
the EPDS to screen for perinatal anxiety disorders (Swalm, Brooks, Doherty, Nathan, & 
Jacques, 2010), while others concluded more research was needed for validation (Evans, 
Spiby, & Morrell, 2015; Matthey, Fisher, & Rowe, 2013). 
Postpartum Depression  
Screening Scale 
The PDSS (Tatano Beck & Gable, 2002) is a 35-item, self-rated, Likert response 
scale that assesses seven dimensions including sleeping and eating patterns, anxiety and 
insecurity, emotional lability, cognitive impairment, loss of self, guilt and shame, and 
thoughts of self-harm.  Women are asked to rate their symptoms in the previous two 
weeks on a 5-point scale.  Scores range from 35-135 with scores of 60 or greater 
indicating significant symptoms of depression and 80 or greater indicating a positive 
screen for major depression.  The PDSS is less widely validated than the EPDS but 
literature indicates it performs similarly in terms of sensitivity and specificity (Milgrom 
& Gemmill, 2014).  The tool is published in English and Spanish at approximately a third 
to seventh grade reading level.  It is available for purchase for $85 for 25 test forms and a 
scoring manual.   
Patient Health Questionnaire-9  
The PHQ-9 (Kroenke et al., 2001) is a brief, nine-item, self-administered screen.  
Questions correlate to DSM-5 (APA, 2013) criteria for a major depressive episode 
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including questions about interest in previously enjoyed activities; feeling of depression; 
changes in energy, sleep, concentration, and appetite; psychomotor agitation or 
retardation; low self-image; and thoughts of death or self-harm.  Subjects rate symptom 
frequency over the previous two weeks using a Likert scale of 0-3.  Total scores of 0-4 
suggest minimal or no depression; 5-9 indicate mild depression; 10-14 indicate moderate 
depression; 15-19 indicate moderately severe depression; and scores of 20-27 suggest 
severe depression.  The sensitivity and specificity for major depression are both 
calculated at 88% using a PHQ-9 score of ≥10 (Kroenke et al., 2001).  The PHQ-9 has 
been validated for use screening for prenatal and postpartum depression, though less 
widely so than the EPDS.  It is freely available and has been translated into dozens of 
languages; however, the validity of translations has not been consistently documented.   
In a systematic review and evidence report for the USPSTF, O’Connor et al. 
(2016) found the EPDS was consistently sensitive to perinatal depression across diverse 
populations and languages while concluding “evidence on the accuracy of the PHQ for 
pregnant and postpartum women was very limited” (p. 400).  Neither the evidence report 
nor the Task Force report specifically recommended a single screening tool but 
commented there was evidence that screening instruments could help identify women 
who needed further evaluation and treatment. 
In a 2013 meta-analysis for the Agency for Healthcare Research and Quality, 
Myers et al. found a wide range of cutoff values and vague descriptions of testing 
protocols in the studies of various screening tools, leading them to conclude “the ideal 
characteristics of a screening test for postpartum depression, including sensitivity, 
specificity, timing, and frequency, have not been defined” (p. ES-22).  They suggested 
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that initial screening with a two-item instrument (PHQ-2; Kroenke et al., 2003) followed 
by a second, more comprehensive screen, if indicated, might be an appropriate way to 
strike a balance of reducing both false positives and false negatives.  Finally, they 
observed while more studies were needed to elucidate variables, current evidence showed 
the availability and accessibility of follow-up care was significantly more important than 
the choice of one screening tool over the other.     
Mood Disorder Questionnaire  
No instruments have been developed specifically to screen for BD in the perinatal 
period but the Mood Disorder Questionnaire (Hirschfeld, 2002) has been identified as a 
potentially effective tool for such screening.  The MDQ is a 15-item, self-report 
inventory that is freely available.  The screen is divided into three sections: (a) 13 yes-or-
no questions, (b) co-occurring symptoms, and (c) level of functional impairment 
(moderate or serious).  As initially validated in an outpatient psychiatric population, the 
tool had sensitivity of 0.73 and specificity of 0.9 (Sharma & Xie, 2011).  Subsequent 
studies showed variation in sensitivity and specificity depending on the population in 
which it was used and modification or exclusion of Sections 2 and 3.  Frey, Simpson, 
Wright, and Steiner (2012) concluded the ideal scoring algorithm during pregnancy and 
postpartum used cutoff scores of ≥7 and excluded the supplementary questions, resulting 
in sensitivity of 0.88 (95% CI, 0.70–0.98) and specificity of 0.89 (95% CI, 0.82–0.94).  
Sharma and Xie (2011) suggested an optimal cut-off score of ≥8 symptoms endorsed 
without the supplementary questions with sensitivity of 87.72% (95% CI: 76.32%-
94.92%) and specificity of 85.29% (95%CI: 74.61%-92.72%).  
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Citing the common misdiagnosis of BD as MDD and the potential for worsened 
outcomes with inappropriate treatment, Sharma et al. (2018) proposed “changing the 
paradigm” (p. 27) of assessment of PPD so a diagnosis of BD must first be excluded 
before a diagnosis of MDD can be made.  Clark et al. (2015) found that using the MDQ 
in conjunction with the EPDS helped differentiate unipolar depression from bipolar 
depression in up to 70% of women studied.  However, it bears repeating that the MDQ 
and EPDS are both screening instruments, not diagnostic tools, and comprehensive 
evaluation by a mental health professional is imperative for accurate diagnoses.   
Evidence for Screening Intervals 
A review of the available literature did not produce any firm evidence to support 
specific intervals for screening.  In the 2016 recommendation, the USPSTF 
acknowledged, “There is little evidence regarding the optimal timing for screening” and 
encouraged a “pragmatic approach” (Siu, 2016, p. 382).  In the absence of clear evidence, 
organizations have adopted recommendations that range from vague (i.e., ACOG’s 
[2016] suggestion to screen at least once during the perinatal period) to specific (AAP 
[Earls, 2010] recommends screening at the one-, two-, four-, and six-month visits).  The 
latter was based on recognition that postpartum depression tended to peak at six weeks, 
two to three months, and six months after delivery (Earls, 2010).  Yawn, Bertram, 
Kurland, and Wollan (2015) recommended clinicians consider screening for depression at 
6- and 12-months postpartum, noting up to one in three women had elevated depression 
screen scores (PHQ-9 score of ≥10) at those intervals.  In a study of nearly 9,000 women, 
Venkatesh et al. (2016) found women were significantly more likely to complete a 
follow-up mental health evaluation if they had a positive depression screen prior to 
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delivery compared to after delivery.  This might reflect the fact that after birth, women 
are busy caring for a newborn and might have less time or energy to tend to their own 
health needs, thus highlighting the importance of repeated screening at different points in 
the perinatal period.   
Evidence for Follow Up/Referral 
Throughout the literature, there was consensus that screening alone had little to no 
effect on improving outcomes and appropriate follow up, referral to specialists, and 
treatment are imperative (Beck & Gable, 2001; Cox et al., 2016; Milgrom & Gemmill, 
2014).  Although many women might accept screening for depression, they might decline 
or not follow through with referral for further psychiatric evaluation and treatment; 
additional systems and resources are required to enhance engagement.  A variety of 
treatment models have been developed to work in conjunction with universal screening to 
improve women’s access to treatment, enhance continuity of care, and improve clinical 
outcomes.  Most of these models are variations of integrated or stepped-care models, 
which typically deliver treatment in a step-wise fashion, starting with the least resource-
intensive treatment and moving on to more resource-intensive, specialist-provided 
treatment as clinically indicated.    
Gjerdingen, Katon, and Rich (2008) conducted a systematic review of the 
literature in search of the most effective interventions for improving perinatal mental 
health.  In their findings, they described a stepped care system incorporating the 
following:  
1. Screening and diagnosis: screening is completed using a brief, validated tool 
followed by clinical interview, if indicated.  Patient education is provided 
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regarding diagnosis, treatment, and prognosis by the provider or a case 
manager. 
2. Initiation of active treatment: psychotherapy and/or pharmacotherapy.  This 
might be initiated by the primary care (OB) provider or referral to a 
specialist.  
3. Specialty consultation in the primary care setting: if illness is complicated or 
symptoms persist despite initial treatment, consultation with a psychiatric 
specialist would be indicated.  Ideally, this would also be completed within 
the primary care (OB) office. 
4. Referral to specialty care:  should be completed when patients have severe 
or persistent mental illness.   
Benefits of the stepped-care model include more efficient use of resources, 
improved continuity, and improved clinical outcomes.  Gjerdingen et al. (2008) noted 
women were significantly more likely to engage in treatment when it was integrated than 
when they were referred to a distinct office for treatment (71% vs 49%).  If at all 
possible, they recommended specialty psychiatric care be provided on-site within the 
primary care (OB) setting to improve continuity of care, communication, and patient 
engagement.  Case managers (or care managers) are integral parts of the treatment team 
and are able to provide close follow-up and monitoring.   
In their 2013 meta-analysis, Myers et al. found completed referral rates were less 
than 50% except in studies where screening, diagnosis, and treatment were co-located, 
which resulted in “substantially higher” rates of follow up (p. 61).  Venkatesh et al. 
(2016) also observed improved follow through when a social worker in the OB clinic 
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provided in-person or telephone referral to a mental health professional located within the 
same OB clinic.  They also noted the importance of recording screening scores and 
follow up actions in the EMR to prompt providers to continue addressing mental health 
needs in future visits.   
Summary of the Evidence 
A review of the literature showed evidence in support of routine screening for 
mood and anxiety disorders during pregnancy and postpartum.  Professional and 
governmental screening recommendations focused almost exclusively on depression (and 
to a smaller extent anxiety) with very little discussion of BD.  From a psychiatric and 
public health perspective, this might be a dangerous oversight and some experts proposed 
a paradigm shift to prioritize screening for bipolar spectrum disorders.  Merrill et al. 
(2015) noted that initiatives to improve screening for perinatal depression might 
“inadvertently lead to misclassification if there was no simultaneous screening for bipolar 
disorder” (p. 579).  Women with BD who experience symptoms during pregnancy often 
present with depressive or mixed symptoms in early pregnancy; without appropriate 
diagnosis and mood stabilizing treatment, they are at risk for being treated with 
antidepressant monotherapy (Merrill et al., 2015).  Use of antidepressants in BD without 
appropriate mood stabilization could precipitate hypomania, mania, rapid cycling, and 
psychosis, and might increase the risk of suicide or psychosis (Sharma & Xie, 2011).  
Sharma, Khan, Corpse, and Sharma (2008) reported that more than half of patients with 
depressive episodes in the postpartum period actually had BD, suggesting onset of 
depressive symptoms during or after pregnancy might represent a bipolar diathesis.   
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At this time, evidence supports use of the EPDS (Mcbride et al., 2014) for routine 
screening of perinatal depression but does not necessarily rule out use of other validated 
screening tools (PHQ-9, PDSS).  In the absence of clear, overwhelming evidence in one 
direction or the other, it would be reasonable to take into consideration professional 
organizational recommendations, provider preferences, and available resources when 
choosing a depression-screening instrument.  To date, the MDQ (Hirschfeld, 2002) has 
the most evidence to support its use as a screen for BD in pregnant and postpartum 
women.  Evidence supports use of the EPDS and MDQ together for enhanced detection 
of bipolar and major depressive disorders.  There is no clear evidence on the optimal 
intervals at which screening should be completed but consensus is that screening should 
be provided at least once during pregnancy and several times during the first year 
postpartum.  Beyond simply identifying women experiencing or at risk for PMADs, 
routine screening provides an opportunity to discuss risk factors, to educate, and to 
normalize women’s experiences. 
Throughout the literature echoed the consistent refrain that screening does not 
equal diagnosis and screening alone does not improve outcomes.  Prompt evaluation by a 
qualified mental health professional is essential for accurate diagnosis, treatment 
initiation, and follow-up.  Careful clinical assessment is imperative to differentiate 
unipolar MDD from BD because incorrectly applied treatment could be detrimental.  The 
stepped care model and co-location of mental health services in the OB setting were 








CHAPTER III  
DOCTOR OF NURSING PRACTICE PROJECT  
DESIGN AND METHODOLOGY 
The purpose of the DNP scholarly project was to develop a guide for screening, 
referral, assessment, and treatment of PMADs.  This project began by engaging 
stakeholders in a productive, ongoing dialogue and involving them in development of a 
guide that could be used by primary care providers (OB, certified nurse-midwives, family 
practice, pediatrics) to ensure women were being consistently screened, referred, and 
treated, and followed appropriately.  This guide recommends (a) a screening instrument, 
(b) screening intervals, (c) screening and documentation methods, (d) specific clinical 
actions to be taken for certain cutoff scores, and (e) a method for transferring care and 
assessing follow up once risk or symptoms had been identified.  Developing this project 
also provided opportunities for education of clinical and non-clinical staff including brief 
in-services, question-and-answer sessions, and distribution of printed materials.    
Implementation of the guide will occur outside the scope of this scholarly project 
as it will require approval and logistical support from Kootenai Health (2018) 
administration.  Developing a referral destination might take up to a year including time 
to recruit, hire, and onboard appropriate staff.  Implementation of the final guide will 
likely begin with the obstetric practice affiliated with the community hospital (including 
obstetricians and certified nurse midwives) and expand over time to include other local 
OB providers, primary care, and pediatric practices.   
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Stakeholders included providers, nursing, clinical, and administrative staff at 
Kootenai Health (including the Family Birthing Center, Kootenai OBGYN, and Kootenai 
Outpatient Psychiatry), Heritage Health/Family Support Services, Coeur d’ Alene 
Pediatrics, Lakeside Pediatrics, and other local, independent OB providers.   
Project Design and Method 
This project was a non-experimental field study.  The Delphi method was used to 
solicit opinions, experiences, suggestions, and concerns of stakeholders.  Institutional 
Review Board (IRB) approval was granted by the University of Northern Colorado with 
the project classified as "exempt" (see Appendix A); each round of Delphi survey 
questions was approved separately.  The Kootenai Health Nursing Research Coordinator 
authorized this author to distribute the survey to several Kootenai Health employees at 
their institutional "kh.org" emails (see Appendix B).  Invitations to participate in the 
study were sent to participants’ personal or work emails depending on their preference.  
The introductory email included a brief description of the project and its objectives, 
language about informed consent to participate and associated risks/benefits, and a link to 
the online platform SurveyMonkey.  No risks or ethical considerations were identified 
with this field study.  No identifiable patient information was exchanged and data were 
kept on a password-protected computer in a locked office.  Anticipated barriers to 
implementation and engagement included individuals’ reluctance to participate in the 
survey, primarily concern for survey fatigue or time constraints.  To improve 
engagement, the surveys were brief, succinct, and easy to complete.  
The initial round of the Delphi study used multiple choice and open-ended 
questions to query participants’ demographics, comfort/familiarity with various screening 
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tools, current clinical practices, and perceived needs (see Appendix C for consent form 
and Delphi questions).  The second round of the Delphi study presented themes that had 
emerged in the first-round responses and asked participants to approve or reject specific 
steps in a proposed guideline.  Seven individuals participated in the first round of the 
Delphi study and six completed the second round.  Based on feedback from the initial 
survey and supported by evidence in the literature review, the EPDS (Mcbride et al., 
2014) was proposed as a screening instrument and was embedded in the survey for 
participants to review (see Appendix D).  Participants were asked to approve its use, 
along with recommended screening intervals, methods for recording and communicating 
scores, actions clinicians should take based on scores, and methods for referral and 
follow up.   
Results from the second round Delphi survey were adapted into a flowchart (see 
Appendix E) intended for use by emergency department and OB clinicians.  A 
supplementary guideline was developed to provide users with background information, 
evidence underlying the recommendations, talking points, and additional resources (see 
Appendix F).   
Project Evaluation Plan 
The stated primary objective of this scholarly project was to develop a guide to 
improve the mental health care provided to women in Kootenai County (n.d.) during the 
perinatal period.  Evaluation of the project, which will focus on assessing how effectively 
this guide serves the needs of the community, will occur outside the scope of the DNP 
project after the guide had been implemented in the outpatient OB clinic. 
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A group of providers, OBs and certified nurse-midwives in the Kootenai Health 
(2018) outpatient OB clinic will be asked to utilize the guide.  Evaluation will occur after 
one to two weeks; however, depending on patient population characteristics (i.e., very 
few pregnant or postpartum women being see during those weeks), this timeline will be 
extended to collect sufficient data.  Evaluation will occur primarily through chart review 
(with the assistance of the practice’s clinical coordinator) and face-to-face discussion 
with providers.  Charts will be selected for review if they belong to a pregnant or 
postpartum woman seen by a participating provider within the designated screening times 
and will be assessed for use of an appropriate screening tool, documentation of a score, 
and documentation of any subsequent actions for treatment or referral.  Discussion with 
providers will focus largely on their perceptions of the guide and its clinical application, 
and solicitation of any feedback they might have to improve its efficacy.  Other clinical 
and non-clinical staff members will also be interviewed to solicit their feedback about 
processes (i.e., a nurse making referrals to mental health offices might have valuable 
insights to improve workflow).  Finally, providers in the receiving mental health offices 
will be interviewed about their experiences receiving patient referrals from the OB 
offices and asked to provide feedback to help refine the process.   
Timeline 
• March 2019: DNP scholarly project proposal submitted 
• April 2019: Scholarly project proposal defended 
• June 2019: Received University of Northern Colorado Institutional Review 
Board (IRB) approval (see Appendix A) 
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• June/July 2019: First round Delphi study conducted (see Appendix C); 
results synthesized 
• September 2019: Second round Delphi study conducted (see Appendix D), 
results synthesized, guide finalized  
• October 2019: final scholarly project defended 
• Fall 2019––onward: continue development of mental health integration 
Resources 
Few monetary expenses were incurred for development of this scholarly 
project.  Paper, printer cartridges, and additional office supplies were the primary 
expenses and were purchased by this author.  The online platform SurveyMonkey was 
used to disseminate the Delphi study and the author paid for the subscription.  
Participants graciously donated their time to respond to the study and participate in 









DATA ANALYSIS AND RESULTS 
The Delphi method was used to solicit the opinions, experiences, suggestions, and 
concerns of stakeholders.  Participants included OB providers, mental health providers, 
therapists, and clinical social workers.  Most of the participants were employees of 
Kootenai Health and Heritage Health.  One was a certified nurse midwife (CNM) from a 
local OB practice and one was an employee of Bonner General Hospital, a critical access 
hospital located approximately 45 miles north of Kootenai Health.  Kootenai Health 
administrative staff members were invited to participate but did not.  Stakeholders were 
sent an email link to the survey using the online platform SurveyMonkey.  Information 
about privacy practices and informed consent to participate were embedded in the 
invitation email as well as the introduction page on the survey website.  The first survey 
was available online from June 22 through July 22, 2019.  Participation was lower and 
slower than anticipated, possibly due to the summer vacation season.  The surveys 
included multiple choice and open-ended questions.  The first and second round Delphi 
questions are attached in Appendices C and D, respectively.  Responses were kept 
confidential. 
Delphi Round One Questions 
 The first Delphi study solicited demographic information and asked broad 
questions to survey the current/local healthcare landscape and assess perceived need.  
Seven individuals participated in the first round.  The first question asked: “What is your 
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Role of Participants 
 
Role N % 
Administrative 0 0 
OB provider: CNM 1 14.29 
Mental Health Provider: Psychiatrist, NP 3 42.86 
Social Worker 2 28.57 
Therapist 1 14.29 
RN 0 0 
Other 0 0 
Note. One participant, a CNM, inadvertently identified herself as a mental health 
provider. If corrected, two participants were OB providers (28.57%) and two were mental 
health providers (28.57%). 
 
The second question asked: “Do you encounter PMADs in your professional role? 
–either directly, providing patient care, or indirectly, in developing systems/programs.”  
Six respondents (85.71%) answered “Yes” and one (14.29%) participant responded “No.”  
Estimated frequencies given by the participants were “at least twice a week,” 
“approximately 10 patients annually,” “several patients monthly, between 3-5,” “1-2x 




The third question asked: “Are you (or your organization) currently using any sort 
of guideline/protocol in clinical practice with regards to PMADs?”  The majority of 
respondents (4; 57.14%) indicated their organization did not consistently use a clinical 
guideline or protocol for screening and referral of PMADs.  Among respondents whose 
offices/organizations used a screening protocol, there was variability and little detail was 
provided.  One respondent (OB provider) described “q trimester screening, and have a 
protocol for follow up when patients screen positive.  Depending on severity, follow up 
may include additional visits with CNMs, social work, psychiatry, and or/behavioral 
health.”  A mental health provider responded:  
EPDS is provided in the OBGYN clinic at each post-partum visit, prior to referral 
to this office.  Protocols for referral and treatment to psychiatry are being 
developed currently.  Primary issue at this time is that 50% of referrals to 
outpatient psychiatry from OBGYN do not show up for appointment or will not 
schedule.  Are working towards some type of imbedded role within OB clinic.  
Also, desperately need social work/case management role to manage this 
population in order to improve access and adherence to treatment.”  
A social worker wrote:  
I am unsure of the protocol but as a [social worker] on [labor and 
delivery/postpartum] (6 years ago) we were using screening tools. On psychiatric, 
I am unaware that the [emergency department social work] triage staff or the 
therapists [inpatient] use any.   
The fourth question asked: “Are you (or your organization) currently using a 
formal instrument to screen for PMADs?”  Fewer than half the respondents (3; 42.86%) 
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indicated they were using a formal instrument to screen for PMADs.  One was unsure 
which instrument was being used; one was using the EPDS, and one was using the PHQ-
9 and noted: “I dislike that it is not pregnancy specific, but I like that you can follow it 
throughout the patient’s care even after the perinatal period.” 
The fifth question asked: “What would you like to see in a guideline for screening 
and treatment of PMADs? (select as many as apply).”  This question—which asked 
respondents to choose what they would like to see in a guideline for screening/treatment 
of PMADs—should have been published as “select all that apply.”  However, due to the 
author’s error, the survey only allowed participants to select one answer.  Two 
respondents (28.57%) identified “recommended screening tools,” another two (28.57%) 
chose “recommended actions for positive screens,” two (28.57%) chose “referral 
destinations for patient follow up,” and one (14.29%) selected “suggested talking points 
to discuss with patients.”  Two commented that the question should have been “select all” 
and one requested “a more streamlined method for getting patients scheduled/ or invested 
in follow-up […] more community therapists able to work with this population [and] case 
management role would be very helpful.” 
The sixth question asked: “What is your current referral process for women who 
need more specialized mental health treatment?”  Free-text responses included: “[social 
work] staff calling around to see who can take new patients,” “referral to our clinics 
mental health department,” “referrals are sent from the OB clinic to the Outpatient 
Psychiatry clinic.  Phone consult also available between providers.”  Other processes 
mentioned were “referral to generalized counseling services” and “referral to local 
providers, who are overbooked.”  One respondent, an OB provider in a metropolitan area, 
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wrote: “We refer within our system (Kaiser) if resources are available, or to our local 
lactation support center that includes a specialized perinatal mood disorder division.” 
The seventh question asked: “In your professional experience, what proportion of 
women who need specialized mental health treatment receive adequate 
treatment/services?”  Figure 1 provides participants’ responses regarding proportions of 
women who needed specialized mental health treatment and actually received it.  
 
 












The eighth question asked: “From your perspective, what are barriers to the 
screening/assessment/referral/treatment of PMADs in our community?”  Seven 
participants identified a generalized lack of mental health resources (therapists, providers, 
case managers) as well as a lack of specialty resources for this vulnerable population.  
One mental health provider noted: “Stigma seems to prevent women from coming to the 
outpatient psychiatry clinic, and our OB’s have stated that they feel the engagement rate 
would increase with an imbedded provider.”  One social worker identified a “lack of 
inclusion in standards or care and metrics” as a barrier. 
The ninth question asked: “From your perspective, what would most improve the 
care of PMADs in our community?”  Participants provided the following responses: 
• “Available psychiatric providers and skilled therapeutic clinicians.” 
• “Resources that include a team of counselors, NP and support groups for 
just PMAD.” 
• “Medical and mental health provider education; access to recommended 
assessment/screeners; referral resources.” 
• “An actual program with protocols and support from the organization.” 
• “Encouraging providers to have conversations and ask about symptoms, 
educating patients on what to look for and normalizing how they feel.” 
• “Improved education of providers, improved screening and improved 
availability of resources for those in perinatal period.  Lytle Center in Seattle 
is an example of a good start.” 
• “In-house specialized mental health providers, dedicated perinatal social 
worker (we used to have one and now only have generalists that serve the 
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entire campus and don't have specialized knowledge of perinatal-related 
resources.” 
The final question asked: “Do you have any other questions, suggestions, or 
concerns?” The only additional suggestion (from an OB provider) was to provide a list of 
medications that might be indicated by various symptoms.  She noted some providers 
“sometimes feels like [we] just use what [we are] most comfortable prescribing.”   
Analysis of the open-ended questions revealed consistent themes including a 
general consensus that there was a global lack of resources to identify and support 
women at risk for PMADs.  Respondents indicated institutional changes are necessary to 
improve mental health care for this population.  Participants supported standardized use 
of validated screening tools and data analytics, enhanced systems for referral, and 
development of dedicated perinatal mental health services.  Based on responses from the 
first survey and using published algorithms as a guide (Puryear, 2018; UNC, 2016), a 
second round of Delphi questions was developed asking participants to approve or reject 
individual steps in a proposed guideline.  The survey comprised 16 discrete steps and the 
final item was a free-text field asking for questions, comments, and suggestions.  The 
second round of Delphi questions was submitted to the University of Northern 
Colorado’s IRB on August 6, 2019, and was approved on September 6, 2019.  The survey 
was sent to the seven participants who had completed the first round and again included 
information about informed consent, privacy practices, and a link to the online platform 
SurveyMonkey (see Appendix D).  The survey was available from September 10, 2019, 




Delphi Round Two Questions 
 Delphi round two consisted of 16 discrete questions pertaining to the appropriate 
screening instrument (question 1), appropriate screening intervals (questions 2 and 3), 
screening method and recording results in the medical record (question 4), whether the 
emergency department’s clinician judgment should be used to determine whether the 
patient met criteria for admission and if admission was the most appropriate intervention 
(questions 5 through 9), methods of transferring care (questions 10 through 13), and the 
ideal integrated mental health model (questions 15 through 16).  The final item (question 
17) was a free-text field asking for questions, comments, and suggestions.  All six 
participants indicated approval of all 16 discrete questions except for one non-response to 
question 11.  One participant made the following comment in the free-text field: “This is 













This project began—as many do—with personal interest in a topic.  The author 
had been interested in women’s mental health issues for several years and during her first 
pregnancy became more acutely aware of the lack of local resources for PMADs.  This 
DNP scholarly project emerged as an ideal vehicle to transform a personal interest area 
into an actionable, evidence-based intervention.  Over the course of her DNP studies, this 
author’s knowledge of healthcare systems, population-based healthcare, leadership 
strategy, and policy development expanded dramatically and she became increasing 
passionate about directing her energy and skills into the project.  
As the project took shape, this author immersed herself in the subject matter.  She 
progressed from casually reading articles and watching webinars to undertaking a 
comprehensive review of the literature and an appraisal of the evidence.  The author 
developed a deeper understanding of the background and significance of PMADs 
including their risk factors, prevalence, controversies, and impacts.  She identified 
recommended best practices and analyzed the evidence to support them.  She 
confirmed—first through informal conversations and later through a formal, IRB-
approved Delphi study—that PMADs were under-detected and undertreated in her local 
healthcare system and that there was an urgent need in the community for an improved 
system of care.   
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This author used a Delphi study to build consensus across an expert panel of 
stakeholders including OB providers, mental health providers, and social workers.  She 
synthesized evidence from the literature review to propose a guideline and model of care 
to improve the detection, treatment, and follow up of PMADs in the community.  The 
guide met each objective outlined in Chapter III including identifying (a) an appropriate 
screening instrument, (b) appropriate screening intervals, (c) screening methods and 
processes for recording results in the medical record, (d) specific actions the clinician 
should take based on pre-established cutoff scores, and (e) a method for transferring care 
and assessing follow up once risks or symptoms had been identified.  Finally, an 
integrated mental health model was proposed, wherein a social worker and/or PMHNP 
would be embedded in the outpatient OB clinic to improve access and continuity of care.  
The expert panel unanimously approved each step in the guide and affirmed the need for 
ongoing advocacy, investment of resources, and process refinement.  
Limitations 
 This project was completed largely within the KH organization, initially with the 
hope the resulting guideline would be implemented into clinical practice.  However, the 
academic and organizational timelines were asynchronous and as of the time of the 
scholarly project defense, the actual implementation remained theoretical and could not 
be evaluated in situ.  As of late 2019, Kootenai Health leadership was considering 
strategic development goals for 2020 and exploring funding and staffing needs.  The 
author and stakeholders remain optimistic the New Year will bring new opportunities for 
growth and improvement. 
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 No single formula in the literature delineated an “ideal” way to approach PMADs 
from a population perspective.  There are wide variations in current clinical practice 
across communities, states, and the nation.  There are multiple screening instruments, 
possible screening intervals and methods, and various systems for follow up, each of 
which might be influenced by provider preference, organizational culture, and available 
resources.  This guide was designed specifically for use by KH ED staff and OB 
providers who deliver just over half the babies in Kootenai County annually (53%; 
personal communication with Megan Smith, OB nurse manager, July 2018).   
 Obstetrics providers from several other local practices had expressed interest in 
the subject and would benefit from sharing the guide with minor adaptations in the 
referral process (they would likely not have the patient volume to warrant embedding a 
mental health provider in their offices but would like to refer patients to the case manager 
or PMHNP in the Kootenai OBGYN office).  That embedded mental health provider 
could also become a potential referral destination for local pediatrics offices, some of 
which currently screen postpartum mothers but struggle to link women with positive 
screens to appropriate treatment (personal communication with Haley Buhl, pediatric 
nurse practitioner, November 2018).  Establishing an expedited referral process to mental 
health clinicians at Heritage Health and Family Support Services would help expand 
available resources and streamline care, especially in the future if demand within the OB 
office exceeds available clinical time or if women need ongoing mental health services 
after the first year postpartum.     
 This project did not address specific treatment recommendations (medications or 
therapy modalities, for example) and the recommended screening instrument was 
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indicated primarily for depression and anxiety.  Screening for mania, hypomania, and 
psychosis was not directly addressed in the guide; further refinement based on feedback 
and experience will be necessary once the guide is implemented.  
Recommendations 
 Throughout the literature review process and the Delphi study, it was evident 
inadequate mental health services were available across the nation and the author’s 
community.  In recent years, improved advocacy has led to better legislation and 
increased funding for PMAD-related issues but there is still much work to be done.  The 
demand for funding, high-quality research, education, and services should continue to 
intensify.  Kootenai Health and other local organizations should pursue grant funding and 
improved insurance reimbursement and should direct their strategic planning to develop a 
robust perinatal mental health program.   
 Once funding has been approved, a PMHNP and/or case manager should be 
embedded within the OB clinic and the guideline should be implemented promptly.  
Evaluation should be ongoing to ensure that processes are as smooth and effective as 
possible.  Staff across practice setting should be offered continuing education to help 
them improve their knowledge bases and comfort levels in relation to PMADs.  The 
author and other stakeholders would need to stay up-to-date with emerging evidence 
through ongoing education, literature review, and peer consultation.    
 Because postpartum depression tends to peak at six weeks, two to three months, 
and six months after delivery (Earls, 2010), additional screening should be considered 
beyond the six-week postpartum follow-up visit.  In current practice, the six-week 
follow-up visit is often the last contact a woman would have with her OB provider until 
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her next annual exam or next pregnancy.  The American College of Obstetricians and 
Gynecologists (2018) recommended a shift in the delivery of postpartum care, 
encouraging more frequent follow up and increased attention to emotional wellbeing.  As 
local OB providers adapt their practices, screening intervals could be modified to reflect 
community needs.  Coordination with local pediatric providers will be vital as they tend 
to have frequent contact with parents during the child’s first year of life. 
 Additional areas for expansion include community education sessions, support 
groups, peer support programs, and patient education sessions that could be offered pre-
conception, during pregnancy, on the OB unit, and at postpartum follow up.  On a larger 
scale, Idaho should begin to participate in the Pregnancy Risk Assessment Monitoring 
System (PRAMS), a program developed in 1987 as a collaboration between the Centers 
for Disease Control and Prevention (CDC; 2019) and state departments of health to 
reduce perinatal mortality.  A population-based surveillance system, PRAMS identifies 
groups of women and babies at risk and monitors health status, identifies emerging 
issues, and evaluates policies focused on improving infant health.  Data are collected on 
prevalence of depression before, during, and after pregnancy but, unfortunately, Idaho is 
one of only three states that does not participate in PRAMS (CDC, 2019). Joining 
PRAMS would help leaders improve health policy and better allocate resources for 
women and infants in the state.  
Developing a Clinical Practice Guideline 
While the guide developed through this scholarly project was not truly a “clinical 
practice guideline,” which would have had a significantly broader and deeper scope, 
some of the principles and practices of clinical practice guideline development were 
83 
 
employed in this project.  This approach helped this author structure her project to 
effectively translate evidence into clinical practice.  
The Institute of Medicine (Rosenfeld & Shiffman, 2009) identified seven criteria 
for identifying priority in guideline development including disease burden, controversy, 
cost, new evidence, potential impact, public or provider interest, and variation in care.  
Most of these criteria pertained to the screening and treatment of PMADs. 
• Disease burden.  Perinatal mood and anxiety disorders are prevalent and 
serious; they are one of the most common complications of 
pregnancy/childbirth and result in significant impairment, mortality, and 
morbidity (Earls, 2010; O’Hara & Wisner, 2014).  Estimates of prevalence 
in Kootenai County were consistent with national data; yet, the region has 
lower-than-average access to specialized mental health treatment, resulting 
in under-detection and under-treatment (Mental Health America, 2018).   
• Cost.  The economic impacts of PMADs are significant and include direct 
healthcare costs as well as indirect costs from lost wages, diminished 
productivity, and increased healthcare utilization related to comorbid 
conditions (Greenberg et al., 2015; Kessler, 2012).   
• New evidence.  Emerging evidence indicates standardized screening for 
PMADs could improve outcomes when paired with appropriate systems for 
follow up and management (Beck & Gable, 2001; Cox et al., 2016; Milgrom 
& Gemmill, 2014).  In the past decade, integrated and stepped-care models 
have been shown to optimize utilization of valuable mental health resources 
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while improving the quality of care available to vulnerable populations 
(Gjerdingen et al., 2008) 
• Potential impact.  Improving the detection and treatment of PMADs has the 
potential to improve the health of not just the mother but also her child(ren), 
partner, extended family, and community.  Early intervention might help 
minimize or avoid potentially devastating outcomes (Hoffman et al., 2017; 
Seymour et al., 2014).  A standardized guideline might help improve the 
efficiency and quality of services available to a vulnerable population.   
• Public or provider interest.  Recent years have seen a groundswell of 
awareness of PMADs.  Providers and consumers alike recognize the need 
for improved systems for healthcare delivery.  Local stakeholders in 
Kootenai County have requested evidence-based recommendations to guide 
patient care and systems-level decision making.    
• Variations in care.  Significant differences exist in the detection and 
management of PMADs across practice settings (Evans et al., 2015).  
Professional organizations offer vague recommendations but do not clearly 
define clinical pathways or interventions.  A well-designed guide would 
help reduce variations in care and improve the overall quality of care.    
Once an appropriate topic has been identified, use of a standardized method 
facilitates guideline development.  Shekelle, Woolf, Eccles, and Grimshaw (1999) 
identified five steps integral to the development of evidence-based guidelines including 
(a) identifying and refining the subject area, (b) convening and running guideline 
development groups, (c) assessing evidence identified by systematic literature review, (d) 
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translating evidence into recommendations, and (e) subjecting the guideline to external 
review.   
 In this scholarly project, the author identified and refined the subject area (step 1) 
during the early stages of the endeavor, roughly corresponding to Phase I: Preparation of 
the Stetler (2001) theoretical framework.  As noted in Chapter II, this stage involved 
identifying the problem, defining the purpose and outcomes of the project, affirming 
priorities, and beginning an initial review of sources of information. 
 This project did not utilize guideline development groups (step 2) but did engage 
stakeholders in the development of the guide through ongoing discussion and through the 
Delphi studies.  The third step, assessing evidence identified by systematic literature 
review, corresponded to Stetler’s (2001) Phase II: Validation.  A comprehensive review 
of the relevant literature was undertaken at the beginning of the scholarly project and 
continued during its development.  The fourth step, translating evidence into 
recommendations, corresponded to Stetler’s Phases III: Comparative Evaluation & 
Decision-Making and IV: Translation/Application.  This was accomplished through use 
of the Delphi study to assess stakeholders’ current practices, perceived needs, barriers, 
and available resources.  High-quality evidence identified in the literature review was 
translated into a clinically relevant guide that fit the needs of the target population.   
The final step, subjecting the guideline to external review, was partially 
accomplished in Round 2 of the Delphi study, wherein participants were asked to approve 
or reject 16 steps of the proposed guideline.  Further external review will be completed 
if/when the guide is implemented in the organization.  This would correspond to Stetler’s 
86 
 
(2001) Phase V: Evaluation, and would include discussion with stakeholders, chart audit, 
and case review.    
Reflections on Doctor of Nursing Practice Education 
The AACN (2006) described the Doctor of Nursing Practice degree as the 
“practice-focused” terminal degree of nursing education (p. 3).  Rather than generating 
knowledge or developing theories as their Ph.D. colleagues might, the skill of the DNP-
prepared nurse lies in his/her ability to translate evidence into clinical practice, to 
synthesize data, and to apply it constructively and collaboratively to improve systems and 
practices with the goal of improving the health of individuals and populations.    
In their 2006 document entitled The Essentials of Doctoral Education for 
Advanced Nursing Practice, the AACN detailed eight core competencies of DNP 
education and practice.   These, in conjunction with specialized clinical content 
established by national specialty nursing organizations, form the two major components 
of DNP curricula.  The congruence of the author’s DNP education at the University of 
Northern Colorado (UNC) and her scholarly project with those essential components are 
discussed below.  The scholarly project’s success was evaluated using the acronym EC as 
PIE (enhance, culmination, partnership, implement, and evaluation), which has been 




Essentials of Doctoral Education for  
Advanced Nursing Practice 
Essential I: Scientific Underpinnings  
for Practice 
The DNP curriculum at UNC involved rigorous studies across the natural and 
social sciences.  Coursework included statistics, epidemiology, population health 
management, healthcare finance, leadership, health policy, and nursing theory.  The 
scholarly project incorporated evidence and knowledge from multiple sources and 
specialty areas.  By undertaking a comprehensive review of literature, the author 
developed a deeper understanding of the etiology and treatment of PMADs as well as 
social factors that influence the delivery of health care.   
Essential II: Organizational and  
Systems Leadership for Quality  
Improvement and Systems  
Thinking 
Through her leadership courses and practicum, the author had the opportunity to 
learn about local healthcare systems and effective leadership strategies.  This knowledge 
prepared her to more effectively propose changes.  She also formed professional 
relationships during the practicum that helped facilitate discussions during the project 
development phase.   
Developing the scholarly project required the author to step outside her familiar 
role as a direct provider of healthcare into a position where her focus expanded to the 
entire community.  This shift was challenging—and at times uncomfortable—but 
provided invaluable learning experiences.  A shortage of qualified perinatal mental health 
providers exists and developing more efficient systems within existing organizations 
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would be the most efficient and sustainable way to improve the quality of care and 
expand access.    
Essential III: Clinical Scholarship and  
Analytical Methods for Evidence- 
Based Practice 
Translation of evidence into action is the foundation of advanced nursing practice.  
Courses in epidemiology, research methods, and statistics prepared the author to assess 
and synthesize evidence and to apply it to clinical practice.  The author used critical 
thinking, a comprehensive literature review, and data analysis to assess needs, identify 
best practices, and develop a guide to improve patient-centered care.  She proposed 
methods for ongoing collection of evidence to further refine interventions and improve 
outcomes.   
Essential IV: Information Systems/Technology  
and Patient Care Technology for the  
Improvement and Transformation  
of Health Care 
 
The author displayed proficiency using a web-based survey platform to collect 
and synthesize data.  She used online databases to search for relevant literature.  The 
author expanded her familiarity with Kootenai Health’s electronic health record (EHR) 
and identified ways in which data could be more accurately collected and managed.   
Essential V:  Health Care Policy for  
Advocacy in Health Care 
The delivery of healthcare is influenced by policies on organizational, local, state, 
and national levels and DNP-prepared nurses are well qualified to effect change on each 
of those levels.  The UNC healthcare policy courses provided the author with a solid 
understanding of how policies are developed and prepared her to advocate for change.  
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This scholarly project sought to influence policy on the organizational level, specifically 
by advocating for expanded allocation of resources to benefit a vulnerable population.  
The author also mobilized local stakeholders to advocate on behalf of their clients for 
additional mental health services.  
Essential VI: Interprofessional Collaboration  
for Improving Patient and Population  
Health Outcomes 
Perinatal mental health sits at the confluence of mental health, women’s health, 
primary care, and pediatrics.  This scholarly project required collaboration across 
different healthcare specialties and settings—from outpatient OB to labor and delivery, 
from the emergency department to psychiatry.  The author participated in collaborative 
meetings with OB, mental health, primary care, and pediatric providers, as well as 
Kootenai Health leadership, and helped facilitate communication across specialty areas.  
Apart from the scholarly project, she was able to provide an educational in-service to 
community midwives and OB providers and phone consultation for OB and mental health 
providers.  She has been working with the labor and delivery unit to develop an 
educational video that all mothers will watch before being discharged from the hospital.  
Essential VII: Clinical Prevention and  
Population Health for Improving the  
Nation’s Health 
The primary purpose of this scholarly project was to develop a comprehensive 
guide to improve mental health care provided to women in Kootenai County during the 
perinatal period.  The DNP-prepared nurse is ideally positioned to enact population-level 
interventions, which is critical in the field of mental health given the global shortage of 
specialists, and this need is even more pronounced in the specialty area of PMADs.  The 
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University of Northern Colorado’s DNP curriculum prepared the author to evaluate 
current care delivery models and synthesize findings from current literature and the local 
community into a framework that would improve the quality of care for an underserved, 
vulnerable population.  
Essential VIII: Advanced Nursing  
Practice 
The University of Northern Colorado’s DNP curriculum provided the author with 
new educational (and eventually professional) opportunities.  After completing advanced 
practicum clinical hours at KH in the first year of the program, she was invited to join the 
organization full-time.  Her clinical skills sharpened with immersion in new healthcare 
settings and eventually the DNP program challenged the author to expand her focus from 
providing direct patient care to developing systems-based interventions.  She has 
immersed herself in a specialty area and has had the privilege of being a preceptor to 
nurse practitioner students.  She has also had the opportunity to provide PMAD education 
to colleagues across the community.  Through the course of study, the author has 
developed the clinical judgment, analytical skills, and ability to work collaboratively, 
which are the hallmarks of advanced practice nursing. 
Enhance, Culmination, Partnership,  
Implement, and Evaluation 
Waldrop, Caruso, Fuchs, and Hypes (2014) proposed “EC as PIE” as a method of 
evaluating “whether a DNP final project meets the outcomes of the AACN’s Essentials of 
Doctoral Education in Advanced Nursing Practice” (p. 300).  The authors noted that with 
the proliferation of DNP programs since 2006—and wide variations in curricula and 
academic rigor—it is imperative to ensure the DNP graduate has truly met the outcomes 
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established by the AACN (2006).  The acronym EC as PIE represents five criteria that 
must be met by a DNP scholarly project.   
• E = Enhance health outcomes, practice outcomes, or health policy.  The 
author evaluated current practices and found that screening, referral, 
treatment, and follow up of PMADs in her community were inconsistent, 
resources were inefficiently distributed, and patient outcomes were 
adversely impacted.  The scholarly project proposed comprehensive changes 
to improve the quality and consistency of care to improve outcomes across 
practice settings. 
• C = Reflect a culmination of practice inquiry.  During development of this 
scholarly project, the author immersed herself in the subject matter from 
clinical and systems perspectives.  She undertook advanced training and 
became certified as a perinatal mental health provider through Postpartum 
Support International.  She gained a deep and broad understanding of 
historical issues, best practices, scientific developments, and legislative 
efforts in the field and used this knowledge to effect change. 
• P = Require engagement in partnerships.  The author collaborated with 
stakeholders across the community from diverse backgrounds including 
direct healthcare providers, healthcare administrators, and consumers.  She 
found many colleagues had been personally impacted by PMADs and were 
fiercely supportive of the project.   
• I = Implement/apply/translate evidence into practice.  The author first 
gathered evidence through the literature review process and then synthesized 
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it into a recommended plan of action that fit the needs of the local 
community.   
• E = Require evaluation of health care, practice, or policy outcomes.  The 
initial stages of this scholarly project involved evaluating the current 
processes for screening, referral, treatment, and follow up of PMADs.  The 
author has proposed a method of ongoing evaluation once the proposed 
guide/practice model is implemented. 
Conclusion 
Perinatal mood and anxiety disorders are serious, prevalent, and treatable but 
under-detection, exacerbated by inadequate/inefficient use of resources, has resulted in 
many women not receiving appropriate treatment.  Improved systems for screening, 
detection, referral, treatment, and follow up of women with or at risk for PMADs are 
imperative to protect the health of women, their children, families, and communities.  
This scholarly project examined current literature to identify best-practices and proposed 
a model of care to improve health outcomes across a community.  This author built 
support for her project and formed a coalition of mental health and OB professionals who 
continue to work collaboratively to enhance the quality of care in Kootenai County.  
Ongoing work is needed to implement and evaluate the guide and to expand services to 
further match the community’s needs.   
The DNP-prepared nurse is able to adapt to the ever-changing healthcare 
landscape and is uniquely qualified to effect change across varied and complex settings.  
This project embodied the integration of scholarly interest, clinical expertise, and 
advanced nursing practice.  As she transitions from student to graduate, this author will 
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continue to hone her skills, expand her knowledge base, and collaborate across the 
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CONSENT FORM FOR HUMAN PARTICIPATION IN RESEARCH  
Project title: Perinatal Mental Health:  
Improving the Quality and Consistency of Healthcare Delivery in Kootenai County 
 
Student Researcher: Leanne Elisha, PMHNP (DNP Student)  
Research Advisor: Kathleen N. Dunemn, PhD, APRN, CNM, School of Nursing  
Co-Advisor: [name, credentials] 
Committee Member: [name, credentials] 
Expert Consensus via a Delphi Study 
Dear Participant, I am completing a DNP Scholarly Project to improve perinatal mental 
health care in Kootenai County.  
The primary goal of this project is to develop a guide to improve identification, referral, 
treatment, and follow-up perinatal mood and anxiety disorders (PMADs).  This guide will 
identify:  
1. An appropriate screening instrument 
2. Appropriate screening intervals 
3. Screening method and process for recording results in the medical record 
4. Specific actions the clinician should take based on pre-established cutoff scores 
5. A method for transferring care and assessing follow up once risk or symptoms 
have been identified. 
6. A proposed model for integrating mental health into the primary care/OB setting. 
 
The Delphi Method will be used to solicit stakeholder opinion, interest, and feedback and 
to build consensus.  It is anticipated that two rounds will be necessary for completion of 
this project.  The first round of questions will focus on general awareness of PMADs, 
screening recommendations, and current practice, as well as areas of perceived need.  
Subsequent rounds will focus on building consensus and developing a practical guide to 
improve clinical practice.  
 
All Delphi surveys will be sent and returned electronically with a private e-mail account 
only accessible by the DNP student. It is estimated that each participant will spend 
approximately 10-15 minutes in completion of survey questions within each round of the 
Delphi process.  
 
Delphi survey responses will be kept confidential. Participation is voluntary. If you 
know any providers or stakeholders that may be interested in participating in these 
surveys, please forward this email to them. If you begin to participate, you may decide to 
stop or withdraw at any time. If you have any questions, please contact one of the 
undersigned. Having read the above document and having had an opportunity to ask any 
questions, please access the link [insert survey link] to complete the survey.  
If you complete the survey, it will be assumed that you have communicated consent for 
your participation. You may keep this form for future reference. If you have any concerns 
about your selection or treatment as a research participant, please contact Sherry May, 
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IRB Administrator, office of Sponsored Programs, Kepner, Hall, University if Northern 
Colorado, Greeley, Co 80639. Phone 970-351-1910.  
 
This informed consent will be e-mailed and accompany each round of the Delphi study. 
 
Student Researcher: Leanne Elisha, PMHNP, DNP-S.email: 
elis5570@bears.unco.eduPhone:  
Research Advisor: Kathleen N. Dunemn, PhD, APRN, CNM. email: 
Kathleen.Dunemn@unco.eduPhone: (970) 351-3081/ (303) 649-5581  
Co-Research Advisor: [name, credentials], [email], [phone]  





Round One Delphi Questions: 
Thank you for your participation in this survey.  The objective of this project is to 
improve the detection, referral, and treatment of perinatal mental health issues in our 
community.  The questions below pertain to perinatal mental health issues, including 
pre/postpartum depression, anxiety, mania, and psychosis, collectively referred to as 
perinatal mood and anxiety disorders (PMADs).  Please answer as fully as possible and 
feel free to elaborate or qualify your responses.  All responses will be kept confidential.  
If you have any specific questions regarding the survey or the project, please email 
Leanne Elisha at lelisha@kh.org. 
1) What is your role?   
o Administrative: _______ 
o OB provider: (CNM, OB) 
o Mental health provider: (psychiatrist, NP) 
o Social worker 
o Therapist: (LPC, MSW, LCSW, etc) 
o RN 
o Other 
2) Do you encounter PMADs in your professional role?  (either directly, providing 
patient care, or indirectly, in developing systems/programs) 





3) Are you (or your organization) currently using any sort of guideline/protocol in 
clinical practice?   
o Yes:   If yes, please describe.  What do you like/dislike about the 
guideline you currently use? _____________________ 
 
o No  
4) Are you (or your organization) currently using a formal tool to screen for PMADs?   
o Yes: If yes, which tool?  What led you to choose this tool?  What do 
you like/dislike about it? ___________________________ 
 
o No  
5) What would you like to see in a guide? 
o Recommended screening tools 
o Recommended screening intervals 
o Suggested talking points to discuss with patients 
o Recommended actions for positive screens 
o Referral sources for patient follow up 
o Local contacts for professional consultation (peer-to-peer consult) 
o Other: ____________________________ 
6) From your perspective, what are barriers to the 
screening/assessment/referral/treatment of PMADs in our community: 
________________________________________________________________ 
7) From your perspective, what would most improve the care of PMADs in our 
community?  
_____________________________________________________________________ 
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CONSENT FORM FOR HUMAN PARTICIPATION IN RESEARCH 
UNIVERSITY OF NORTHERN COLORADO 
Project title: Perinatal Mental Health:  
Improving the Quality and Consistency of Healthcare Delivery in Kootenai County 
 
Student Researcher: Leanne Elisha, MS, PMHNP, DNP-S 
Research Advisor: Kathleen N. Dunemn, PhD, APRN, CNM, School of Nursing  
Committee Member:  Faye Hummel, RN, PhD, CTN-A, ANEF, School of Nursing 
Committee Member:  Carolyn Bottone-Post, DNP, RN, CNM, School of Nursing 
 
Contact Information: 
Student Researcher: Leanne Elisha, MS, PMHNP, DNP-S  
 Email: elis5570@bears.unco.edu 
Research Advisor: Kathleen Dunemn, PhD, APRN, CNM 
 Email: Kathleen.Dunemn@unco.edu 
 Phone: (970) 351-3081/ (303) 649-5581 
 
Expert Consensus via a Delphi Study: Round 2 Delphi Questions 
Project Purpose: Dear Participant, you are invited to participate in Round 2 of my DNP 
Scholarly Project to improve perinatal mental health care in Kootenai County.   
The primary goal of this project is to develop a guideline to improve identification, 
referral, treatment, and follow-up perinatal mood and anxiety disorders (PMADs).  The 
final guideline will identify:  
1. An appropriate screening instrument 
2. Appropriate screening intervals 
3. Screening method and process for recording results in the medical record 
4. Specific actions the clinician should take based on pre-established cutoff scores 
5. A method for transferring care and assessing follow up once risk or symptoms 
have been identified. 
6. A proposed model for integrating mental health into the primary care/OB setting. 
 
Project Description:  The Delphi Method will be used to solicit stakeholder opinion, 
interest, and feedback and to build consensus.  It is anticipated that two rounds will be 
necessary for completion of this project.  The first round of questions focused on general 
awareness of PMADs, screening recommendations, and current practice, as well as areas 
of perceived need.  This round focuses on building consensus and developing a practical 
guideline to improve clinical practice.  
 
In the first round of the Delphi study you were asked to respond to ten (10) questions 
related to perinatal mental health issues.  This round contains sixteen (16) questions.  
Each asks you to approve or reject a proposed step in the guideline.  Comments are 
invited on all questions but not required.  It is estimated that it will take 10-15 minutes to 
complete these questions.  No compensation will be offered.  There will be no form of 




Risks and Benefits of Participation: The risks inherent in this study are no greater than 
those normally encountered during regular daily activities.  The potential benefit of this 
study is enhanced provider/administrator engagement in the development of improved 
systems for providing care to an underserved population.   
 
Confidentiality Procedures:  Delphi survey responses will be kept confidential.  All 
Delphi surveys will be sent and returned electronically with a private e-mail account only 
accessible by the DNP student.  Data will be stored on a password-protected computer in 
a locked office.  Responses to questions will be kept confidential, but because the panel 
of experts has been hand-selected by the student researcher and the project may include 
face-to-face discussion and focus groups, anonymity is neither inferred nor assured. 
 
Participation is voluntary.  If you begin to participate, you may decide to stop or 
withdraw at any time. If you have any questions, please contact one of the undersigned. 
Having read the above document and having had an opportunity to ask any questions, 
please access the link [insert survey link] to complete the survey.  
If you complete the survey, it will be assumed that you have communicated consent for 
your participation. You may keep this form for future reference. If you have any concerns 
about your selection or treatment as a research participant, please contact Sherry May, 
IRB Administrator, office of Sponsored Programs, Kepner, Hall, University if Northern 




Round 2 Delphi Questions 
 
Thank you for your participation in the first round and for your feedback.  
 
Your responses are consistent with themes in the literature.  Identified themes include: 
there are insufficient resources available to detect, much less treat, perinatal mood and 
anxiety disorders (PMADs).  Specialized clinicians and referral destinations must be 
identified/developed.  Stigma around mental health issues interferes with treatment 
engagement and lowers participation.  Institutional support is required to build a more 
coherent, accessible system to care for these patients.   
 
Based on your responses, I have proposed a model of care.  Please take the time to review 
the proposal below and approve or reject each item.  Feedback is greatly appreciated.  
This is currently a theoretical project; actual implementation will require administrative 
investment and support.   
 
Regarding the assessment and care of PMADs in the Kootenai Health system, please 
approve or reject the following: 
 
Appropriate screening instrument: 
1. Kootenai Health OB providers will begin screening pregnant and postpartum 
women for PMADs using the Edinburgh Postnatal Depression Scale (EPDS).  
This tool is attached for easy reference. 
o Rationale: 
▪ EPDS is a widely used, freely available tool that is validated for 
assessment of postpartum and antennal depression (McBride et al., 
2014). 
▪ The EPDS is a 10-item, self-administered screen that can be scored 
in approximately 5 minutes without specialized training. 
▪ The EPDS specifically excludes questions about neurovegetative 
symptoms (changes in sleep or appetite) that may be non-
pathological in this population. 







Appropriate screening intervals: 
2. In the OB setting, PMAD screening will be performed at New OB, prenatal 28-
32-week, lactation problem, and 6-week postpartum visits. 
o Rationale:  
▪ “There is little evidence regarding the optimal timing for 
screening” and a “pragmatic approach” should be used (Siu, 2016). 
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▪ Women are significantly more likely to complete follow up mental 
health evaluation if they had a positive depression screen prior to 
delivery compared to after delivery (Venkatesh et al., 2016).   
▪ Depression during pregnancy is one of the strongest risk factors for 
postpartum depression (Paschetta et al., 2014). 
▪ Postpartum depression tends to peak at 6 weeks, 2-3 months, and 6 






3. In the Emergency Department setting, women presenting to the ED with mental 
health concerns will be asked “are you pregnant, or have you been pregnant 
within the past year?” If the response if affirmative, case managers will 
administer the EPDS. 
o Rationale:   
▪ There is currently no standardized method of identifying 
pregnant/postpartum in the ED, nor is there a way of tracking ED 
utilization for this population.  Standardized screening and data 
integration into the EHR (as a searchable value) will help identify 






Screening method and recording results in the medical record: 
4. In the OB office or the ED, the nurse/case manager will give the patient a 
clipboard with a paper copy of the EPDS and allow them to complete it privately.  
The nurse/case manager will review the score, enter the responses into the EHR, 
and communicate the results to the provider (in the ED this includes the ED 
provider and the on-call psychiatrist). 
o Rationale:  
▪ The EPDS is designed to be self-administered.  Values can be 
quickly recorded in an EPIC EPDS flow-sheet allowing quick, 
easy access by clinicians across the spectrum of care. (Until the 
KH transition to EPIC, outpatient scores will be recorded in 









Specific actions based on scores (questions 5-9 refer primarily to the outpatient 
setting; in the ED clinician judgment should be used to determine whether the 
patient meets criteria for admission and if admission is the most appropriate 
intervention):  
5. The provider will review the EPDS results and follow up directly with the patient 






6. Special attention should be given to any positive responses to #10 (“Are your 
worries or mood changing the way you do things?  Are you having any scary 
thoughts?”)  Sound clinical judgment should be used in interpreting 






7. For scores <10: (minimal symptoms) 
o Scores <6: Provide encouragement, supportive counseling, education, and 
encourage the patient to reach out if symptoms change (increase). 







8. For scores 10-12: (mild to moderate symptoms) 







9. For scores of >12 (suggestive of major depression) OR positive response to 
Question #10: 
o Assess for safety: is there acute concern for psychiatric illness? (potential 
for harm to self/others; inability to care for self/baby?) 
▪ No: Refer to counseling; consider use of antidepressant 




▪ Yes: If immediate concern for harm to self or others, arrange for 






Method for transferring care: (these are dependent upon the proposed model 
described below) 
10. In the OB clinic, the clinician will ask the patient if she is currently established 






11. If yes, she will be referred back to that provider for follow up.  A designee in the 
OB office will contact the mental health clinician’s office with the results of the 












13. For any OB office patient with an EPDS score => 12, the OB social worker will 











Ideal integrated behavioral health model: 
14. In this proposed model, mental health services would be co-located in the 
outpatient OB office.   
o Rationale:  
▪ Co-location improves treatment adherence because it normalizes 






15. A full-time clinician (ideally a social worker) would work in the OB office 
providing crisis intervention, case management, and psychotherapy.   
o Rationale:  
▪ A social worker (LCSW, LMSW) is ideally suited to match the 
varying needs of this population.  They can help the patient 
navigate the healthcare system and can provide direct clinical care. 
▪ Follow through rates improve when social workers are embedded 






16. A part-time psychiatric nurse practitioner would work in the OB office providing 
diagnostic assessment, consultations, and medication management.  These 
services would be available to patients from across the community, not restricted 
to Kootenai Health clients.  Phone consultation could be available outside office 
hours. 
o Rationale:  
▪ The NP would have the flexibility to assume full care of some 
patient’s mental health needs, especially in complicated cases that 
OB providers are not comfortable handling, or to provide clinical 
consultation to the KH and community providers to optimize 
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